<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Genomics</journal-id><journal-title-group><journal-title>BMC Genomics</journal-title></journal-title-group><issn pub-type="epub">1471-2164</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">2900271</article-id><article-id pub-id-type="publisher-id">1471-2164-11-398</article-id><article-id pub-id-type="pmid">20573200</article-id><article-id pub-id-type="doi">10.1186/1471-2164-11-398</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Characterization of the equine skeletal muscle transcriptome identifies novel functional responses to exercise training</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>McGivney</surname><given-names>Beatrice A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>beatrice.mcgivney@ucd.ie</email></contrib><contrib contrib-type="author" id="A2"><name><surname>McGettigan</surname><given-names>Paul A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>paul.mcgettigan@ucd.ie</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Browne</surname><given-names>John A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>john.a.browne@ucd.ie</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Evans</surname><given-names>Alexander CO</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref><email>alex.evans@ucd.ie</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Fonseca</surname><given-names>Rita G</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>rita.fonseca@ucdconnect.ie</email></contrib><contrib contrib-type="author" id="A6"><name><surname>Loftus</surname><given-names>Brendan J</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>amanda.lohan@ucd.ie</email></contrib><contrib contrib-type="author" id="A7"><name><surname>Lohan</surname><given-names>Amanda</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>brendan.loftus@ucd.ie</email></contrib><contrib contrib-type="author" id="A8"><name><surname>MacHugh</surname><given-names>David E</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref><email>david.machugh@ucd.ie</email></contrib><contrib contrib-type="author" id="A9"><name><surname>Murphy</surname><given-names>Barbara A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>barbara.murphy@ucd.ie</email></contrib><contrib contrib-type="author" id="A10"><name><surname>Katz</surname><given-names>Lisa M</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>lisa.katz@ucd.ie</email></contrib><contrib contrib-type="author" corresp="yes" id="A11"><name><surname>Hill</surname><given-names>Emmeline W</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>emmeline.hill@ucd.ie</email></contrib></contrib-group><aff id="I1"><label>1</label>Animal Genomics Laboratory, UCD School of Agriculture, Food Science and Veterinary Medicine, College of Life Sciences, University College Dublin, Belfield, Dublin 4, Ireland</aff><aff id="I2"><label>2</label>University Veterinary Hospital, UCD School of Agriculture, Food Science and Veterinary Medicine, College of Life Sciences, University College Dublin, Belfield, Dublin 4, Ireland</aff><aff id="I3"><label>3</label>UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland</aff><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>23</day><month>6</month><year>2010</year></pub-date><volume>11</volume><fpage>398</fpage><lpage>398</lpage><history><date date-type="received"><day>18</day><month>2</month><year>2010</year></date><date date-type="accepted"><day>23</day><month>6</month><year>2010</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2010 McGivney et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2010</copyright-year><copyright-holder>McGivney et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1471-2164/11/398"/><abstract><sec><title>Background</title><p>Digital gene expression profiling was used to characterize the assembly of genes expressed in equine skeletal muscle and to identify the subset of genes that were differentially expressed following a ten-month period of exercise training. The study cohort comprised seven Thoroughbred racehorses from a single training yard. Skeletal muscle biopsies were collected at rest from the <italic>gluteus medius </italic>at two time points: T<sub>1 </sub>- untrained, (9 &#x000b1; 0.5 months old) and T<sub>2 </sub>- trained (20 &#x000b1; 0.7 months old).</p></sec><sec><title>Results</title><p>The most abundant mRNA transcripts in the muscle transcriptome were those involved in muscle contraction, aerobic respiration and mitochondrial function. A previously unreported over-representation of genes related to RNA processing, the stress response and proteolysis was observed. Following training 92 tags were differentially expressed of which 74 were annotated. Sixteen genes showed increased expression, including the mitochondrial genes <italic>ACADVL</italic>, <italic>MRPS21 </italic>and <italic>SLC25A29 </italic>encoded by the nuclear genome. Among the 58 genes with decreased expression, <italic>MSTN</italic>, a negative regulator of muscle growth, had the greatest decrease.</p><p>Functional analysis of all expressed genes using FatiScan revealed an asymmetric distribution of 482 Gene Ontology (GO) groups and 18 KEGG pathways. Functional groups displaying highly significant (<italic>P </italic>&#x0003c; 0.0001) increased expression included mitochondrion, oxidative phosphorylation and fatty acid metabolism while functional groups with decreased expression were mainly associated with structural genes and included the sarcoplasm, laminin complex and cytoskeleton.</p></sec><sec><title>Conclusion</title><p>Exercise training in Thoroughbred racehorses results in coordinate changes in the gene expression of functional groups of genes related to metabolism, oxidative phosphorylation and muscle structure.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>The phenotypic and biochemical changes occurring in response to exercise training have been extensively studied in humans and mammals, the results mainly being of a descriptive nature. The adaptive response to training is dependent on variations in exercise-induced changes in muscle load, energy requirements and calcium flux. Endurance training results in increased aerobic capacity [<xref ref-type="bibr" rid="B1">1</xref>], mitochondrial biogenesis [<xref ref-type="bibr" rid="B2">2</xref>] and a shift from carbohydrate to fat metabolism [<xref ref-type="bibr" rid="B3">3</xref>] whereas resistance training promotes protein synthesis [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>], muscle hypertrophy [<xref ref-type="bibr" rid="B6">6</xref>] and a switch from slow to fast twitch muscle. Numerous equine studies have also confirmed an increase in VO<sub>2max </sub>and an increase in oxidative enzyme activity [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B12">12</xref>] following endurance training. An increase in type II and a concurrent decrease in type IIX fibres is observed in Thoroughbreds in response to high intensity training [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. Also, anerobic capacity and speed and strength have been observed to increase following short duration high intensity (~100-150% VO<sub>2max</sub>) exercise [<xref ref-type="bibr" rid="B14">14</xref>-<xref ref-type="bibr" rid="B16">16</xref>].</p><p>In contrast, much less is known regarding the transcriptional reprogramming underlying the highly specific adaptive responses to endurance and resistance exercise. Exercise studies using human subjects and animal models have demonstrated that changes in the expression of a wide range of mRNA transcripts play a major role in the recovery of muscle following exercise with the expression levels of most genes returning to baseline within 24 hours [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B23">23</xref>]. However, it appears that repeated bouts of exercise lead to new basal levels of gene expression in resting muscle. Higher levels of mitochondrial genes and genes involved in energy metabolism were observed in endurance trained athletes compared to sedentary subjects [<xref ref-type="bibr" rid="B24">24</xref>]. Further evidence for a new steady state level of exercise related genes comes from a recent study in which differential levels of gene expression were observed in resting skeletal muscle from sedentary, endurance trained and resistance trained subjects. However the use of intra rather than inter-individual genetic comparisons as well as different training stimuli may have contributed to the observed differences in gene expression between the groups. The majority of differentially expressed genes were common to both trained states [<xref ref-type="bibr" rid="B25">25</xref>]. A surprisingly small number of genes were differentially expressed between endurance trained and resistance trained subjects given the very different phenotypic changes and distinct signalling pathways [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>] associated with each form of exercise. Studies have indicated that concurrent endurance and resistance training results in impaired strength development and aerobic capacity when compared to a training regime with a single exercise mode [<xref ref-type="bibr" rid="B28">28</xref>-<xref ref-type="bibr" rid="B31">31</xref>] a phenomenon described as the interference effect. However, conflicting studies have found little or no effect of a combined training regime on strength and aerobic capacity [<xref ref-type="bibr" rid="B32">32</xref>-<xref ref-type="bibr" rid="B35">35</xref>]. The aim of this study was to investigate the global transcriptional response in skeletal muscle to a training regime combining endurance and high intensity sprint exercise in Thoroughbred racehorses. We hypothesise that following training differential expression of genes related to both aerobic capacity and muscle hypertrophy will be observed reflecting the dual nature of the training regime.</p><p>The Thoroughbred is a novel and valuable model for identifying molecular mechanisms basic to both endurance and resistance adaptive responses. Competitive horse racing dates to 4500 BC and Thoroughbreds have been bred for speed and stamina since the 1700 s. This intense selection has resulted in a highly adapted athlete [<xref ref-type="bibr" rid="B36">36</xref>]. Thoroughbreds have a very high aerobic capacity or maximal oxygen uptake (VO<sub>2max</sub>) [<xref ref-type="bibr" rid="B37">37</xref>] relative to their body mass. For instance, VO<sub>2max </sub>can reach 180-200 mL O<sub>2</sub>/min/kg, approximately 2.5 times higher than other species of similar size[<xref ref-type="bibr" rid="B38">38</xref>]. This is achieved through a large lung volume, high cardiac output, high haemoglobin concentration, high muscle mitochondrial volume and a high skeletal muscle mass [<xref ref-type="bibr" rid="B38">38</xref>-<xref ref-type="bibr" rid="B44">44</xref>]. During intense exercise such as under racing conditions a Thoroughbred may increase its metabolic rate from basal levels by up to 60-fold [<xref ref-type="bibr" rid="B45">45</xref>]. Furthermore, the Thoroughbred has a very high skeletal muscle mass comprising over 55% of total body mass [<xref ref-type="bibr" rid="B46">46</xref>].</p><p>A Thoroughbred racehorse trained for flat racing undergoes a training regime comprising intermittent days of sprint exercise to promote increased muscle mass among periods of prolonged exercise at a slower pace to enhance aerobic capacity. In a previous study we detected molecular signatures of both endurance and resistance exercise in untrained Thoroughbred skeletal muscle following a single bout of exhaustive exercise [<xref ref-type="bibr" rid="B47">47</xref>]. A further advantage of using Thoroughbreds as an exercise model is that inter-individual comparisons can be made between subjects that come from a similar background (genetic and environmental) and have undergone a similar exercise regime with relatively little variation in management. Variations in genetic and environmental conditions cannot be controlled to the same extent in human subjects.</p><p>To-date the main approach to investigating global transcriptional changes has been the use of gene expression microarray platforms [<xref ref-type="bibr" rid="B47">47</xref>-<xref ref-type="bibr" rid="B49">49</xref>]. In this study we have used digital gene expression (DGE, Illumina) profiling to characterize the assembly of genes expressed in equine skeletal muscle and to identify the subset of genes that were differentially expressed following a ten month period of exercise training. DGE is a recently developed alternative to microarray gene expression profiling [<xref ref-type="bibr" rid="B50">50</xref>-<xref ref-type="bibr" rid="B52">52</xref>]. The DGE method involves the generation of a cDNA library with a 17 bp tag generated by restriction digestions for each mRNA transcript. The tags are directly sequenced using the Illumina Genome Analyzer creating millions of short reads. In contrast to microarray technology which is limited to the hybridisation of cDNA to probes printed on the array platform, DGE is not dependent on currently available genome sequence and thus provides a global, hypothesis-free quantitative analysis of the transcriptome. The technique is conceptually similar to serial analysis of gene expression (SAGE) [<xref ref-type="bibr" rid="B53">53</xref>] but substantially less expensive, more general and capable of delivering more information.</p><p>Using this technique we investigated 1) the overrepresentation of functional groups in skeletal muscle relative to the entire genome, 2) the genes differentially expressed in trained relative to untrained skeletal muscle, and 3) the overrepresentation of functional groups in genes differentially expressed following training in skeletal muscle.</p></sec><sec><title>Results and discussion</title><sec><title>Representation of genes by DGE tags</title><p>A limitation of genome wide gene expression analysis using DGE is that it is not possible to evaluate the expression of genes that do not contain a <italic>NlaIII </italic>restriction site and in some cases there is ambiguity regarding the tag-gene matches as a single tag may match to two or more genes. 91% (<italic>n </italic>= 22,996) of equine genes with Ensembl gene IDs (<italic>n </italic>= 25,180) have a <italic>NlaIII </italic>restriction site but 13% of these are not unique; therefore, 78% (<italic>n </italic>= 19,271) of currently annotated equine genes are quantifiable using DGE.</p><p>As poor quality sequence was obtained for one of the samples just 13 samples were used for analysis. Of the 13 samples successfully sequenced a total of 183 million raw reads were generated. Of these 119 million reads passed the Illumina pipeline quality filters. These 119 million usable reads consisted of 17.6 million unique tags. 66% of the usable reads mapped to the horse genome, 30% of the usable reads mapped to the predicted Ensembl gene restriction sites and 36% to the genomic regions.</p><p>The intragenic reads may represent regulatory non-coding RNAs or novel genes. However, more likely is the explanation that these tags are a combination of segments of genes that were excluded from the current annotation (or assembly) of the equine genome; an observation which has been previously reported [<xref ref-type="bibr" rid="B54">54</xref>] as well as tags containing sequencing errors. We expect that as the annotation of the horse transcriptome improves that most of the genomic tags we have sequenced will be reassigned to genic tags. In particular we believe that a <italic>de novo </italic>transcriptome assembly approach (using longer sequencing reads) of the equine muscle transcriptome would enable us to more accurately allocate tags to the correct gene models. In the absence of an accurate muscle transcriptome we believe that the Ensembl horse transcriptome, which is predominantly automatically generated and infers much of the information about gene models by homology from better annotated organisms, represents the best available option for DGE tag mapping.</p><p>The reasons that reads may not match a genomic location include ambiguous reads (same sequence tag present in more than one genomic location), reads overlapping an unannotated exon boundary, sequencing errors or single nucleotide variants present in the tag. Due to the short nature of the reads used in DGE compared to other sequencing protocols it is problematic to correct for SNPs or sequencing errors by allowing mismatched bases. Other protocols (<italic>e.g</italic>. RNAseq), which generate longer tags, can overcome this limitation but they introduce new problems, the most important of which is multiple tags per transcript and a bias towards highly expressed long transcripts [<xref ref-type="bibr" rid="B55">55</xref>]. The intragenic reads may represent regulatory non-coding RNAs or novel genes. However, more likely is the explanation that these tags represent segments of genes that were excluded from the current annotation (or assembly) of the equine genome; an observation which has been previously reported [<xref ref-type="bibr" rid="B54">54</xref>].</p><p>Only the 20% of reads that unambiguously matched Ensembl genes were used for further analysis. These represented 5,068 unique genes, ~25% of annotated equine genes. As some genes were represented by multiple different transcripts these were summed to calculate the total number of reads per gene. Highly expressed genes where &#x0003e; 50,000 tags per million (TPM) were detected made up 39% of all annotated reads. However, the majority of unique genes were expressed at low levels (<italic>i.e</italic>. 2,200 genes, &#x0003c; 40 TPM) and there was an inverse relationship between the level of gene expression and the number of genes expressed (Figure <xref ref-type="fig" rid="F1">1</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Relationship between the number of genes expressed and mRNA abundance</bold>. a - Number of genes compared to tags per million per gene. b - The % of the total number of reads compared to the tags per million per gene.</p></caption><graphic xlink:href="1471-2164-11-398-1"/></fig></sec><sec><title>Functional annotation of muscle transcriptome</title><p>Using the online tool DAVID, 448 gene ontology groups and 14 KEGG pathways were observed to be significantly (FDR = 0.05) overrepresented in skeletal muscle relative to the entire genome. There was a substantial overlap of genes within these functional groups resulting in the overrepresentation of a large number of functionally similar gene ontology groups. Therefore only the highly significant groups are shown in Table <xref ref-type="table" rid="T1">1</xref>. The overrepresentation of mitochondrial genes, and genes involved in muscle contraction and metabolism concurs with current SAGE data [<xref ref-type="bibr" rid="B56">56</xref>]. However, an overrepresentation of genes related to RNA processing, the stress response and proteolysis has not, to our knowledge, previously been reported in the muscle transcriptome. DGE is much more sensitive to the detection of low level transcripts than SAGE and consequently provides greater coverage of the muscle transcriptome. When functional analysis of only the highly expressed genes (those comprising &#x0003e; 0.05% of annotated muscle transcriptome) was performed, the novel overrepresented functional groups were not identified. This indicates that these are comprised of genes expressed at relatively low levels. Furthermore, functional groups involved in muscle contraction and aerobic respiration were more significantly overrepresented among the highly expressed genes (Table <xref ref-type="table" rid="T1">1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Functional groups of genes identified in the equine skeletal muscle transcriptome.</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th align="left" colspan="3">All genes</th><th align="left" colspan="3">High abundance genes</th></tr></thead><tbody><tr><td align="left"><bold>GO ID</bold></td><td align="left"><bold>Term</bold></td><td align="left"><bold>Count</bold></td><td align="left"><bold>FC</bold></td><td align="left"><bold>Adj P</bold></td><td align="left"><bold>Count</bold></td><td align="left"><bold>FC</bold></td><td align="left"><bold>Adj P</bold></td></tr><tr><td colspan="8"><hr/></td></tr><tr><td align="left">GO BP:0008152</td><td align="left">metabolic process</td><td align="left">2468</td><td align="left">1.19</td><td align="left">8.17 &#x000d7; 10<sup>-55</sup></td><td align="left">131</td><td align="left">1.2</td><td align="left">4.13 &#x000d7; 10<sup>-08</sup></td></tr><tr><td align="left">GO MF:0005515</td><td align="left">protein binding</td><td align="left">2122</td><td align="left">1.35</td><td align="left">4.53 &#x000d7; 10<sup>-90</sup></td><td align="left">105</td><td align="left">1.3</td><td align="left">2.88 &#x000d7; 10<sup>-12</sup></td></tr><tr><td align="left">GO CC:0043234</td><td align="left">protein complex</td><td align="left">713</td><td align="left">1.57</td><td align="left">2.75 &#x000d7; 10<sup>-43</sup></td><td align="left">68</td><td align="left">2.9</td><td align="left">1.32 &#x000d7; 10<sup>-15</sup></td></tr><tr><td align="left">GO CC:0005739</td><td align="left">mitochondrion</td><td align="left">407</td><td align="left">1.97</td><td align="left">5.63 &#x000d7; 10<sup>-49</sup></td><td align="left">53</td><td align="left">4.9</td><td align="left">3.71 &#x000d7; 10<sup>-23</sup></td></tr><tr><td align="left">GO BP:0006936</td><td align="left"><italic>muscle contraction</italic></td><td align="left">73</td><td align="left">1.94</td><td align="left">1.78 &#x000d7; 10<sup>-07</sup></td><td align="left">33</td><td align="left">8.7</td><td align="left">3.98 &#x000d7; 10<sup>-17</sup></td></tr><tr><td align="left">hsa00190</td><td align="left"><italic>Oxidative phosphorylation</italic></td><td align="left">56</td><td align="left">1.55</td><td align="left">0.006</td><td align="left">32</td><td align="left">9.5</td><td align="left">4.47 &#x000d7; 10<sup>-18</sup></td></tr><tr><td align="left">GO MF:0003723</td><td align="left">RNA binding</td><td align="left">289</td><td align="left">1.76</td><td align="left">3.84 &#x000d7; 10<sup>-23</sup></td><td align="left">27</td><td align="left">3.3</td><td align="left">3.78 &#x000d7; 10<sup>-06</sup></td></tr><tr><td align="left">GO MF:0009055</td><td align="left"><italic>electron carrier activity</italic></td><td align="left">94</td><td align="left">1.81</td><td align="left">1.47 &#x000d7; 10<sup>-07</sup></td><td align="left">24</td><td align="left">9.4</td><td align="left">1.43 &#x000d7; 10<sup>-11</sup></td></tr><tr><td align="left">GO CC:0043292</td><td align="left"><italic>contractile fibre</italic></td><td align="left">50</td><td align="left">3.37</td><td align="left">3.19 &#x000d7; 10<sup>-17</sup></td><td align="left">23</td><td align="left">29.9</td><td align="left">5.32 &#x000d7; 10<sup>-18</sup></td></tr><tr><td align="left">GO CC:0005840</td><td align="left"><italic>ribosome</italic></td><td align="left">93</td><td align="left">1.32</td><td align="left">1.63 &#x000d7; 10<sup>-02</sup></td><td align="left">21</td><td align="left">5.8</td><td align="left">9.29 &#x000d7; 10<sup>-09</sup></td></tr><tr><td align="left">GO MF:0005524</td><td align="left">ATP binding</td><td align="left">434</td><td align="left">1.28</td><td align="left">1.71 &#x000d7; 10<sup>-07</sup></td><td align="left">20</td><td align="left">1.2</td><td align="left">NS</td></tr><tr><td align="left">GO BP:0006950</td><td align="left">response to stress</td><td align="left">337</td><td align="left">1.39</td><td align="left">9.17 &#x000d7; 10<sup>-10</sup></td><td align="left">19</td><td align="left">1.5</td><td align="left">NS</td></tr><tr><td align="left">GO CC:0044428</td><td align="left">nuclear part</td><td align="left">429</td><td align="left">1.88</td><td align="left">9.51 &#x000d7; 10<sup>-46</sup></td><td align="left">10</td><td align="left">0.8</td><td align="left">NS</td></tr><tr><td align="left">GO BP:0006457</td><td align="left">protein folding</td><td align="left">132</td><td align="left">2.12</td><td align="left">5.64 &#x000d7; 10<sup>-18</sup></td><td align="left">10</td><td align="left">3.1</td><td align="left">0.007</td></tr><tr><td align="left">GO BP:0015031</td><td align="left">protein transport</td><td align="left">290</td><td align="left">1.85</td><td align="left">5.91 &#x000d7; 10<sup>-28</sup></td><td align="left">7</td><td align="left">0.9</td><td align="left">NS</td></tr><tr><td align="left">GO MF:0045182</td><td align="left">translation regulator activity</td><td align="left">76</td><td align="left">2.40</td><td align="left">9.13 &#x000d7; 10<sup>-13</sup></td><td align="left">5</td><td align="left">3.2</td><td align="left">NS</td></tr><tr><td align="left">GO BP:0006396</td><td align="left">RNA processing</td><td align="left">195</td><td align="left">1.90</td><td align="left">8.21 &#x000d7; 10<sup>-20</sup></td><td align="left">4</td><td align="left">0.8</td><td align="left">NS</td></tr><tr><td align="left">GO MF:0008134</td><td align="left">transcription factor binding</td><td align="left">153</td><td align="left">1.67</td><td align="left">1.89 &#x000d7; 10<sup>-09</sup></td><td align="left">4</td><td align="left">0.9</td><td align="left">NS</td></tr><tr><td align="left">hsa00620</td><td align="left">Pyruvate metabolism</td><td align="left">27</td><td align="left">2.28</td><td align="left">3.30 &#x000d7; 10<sup>-04</sup></td><td align="left">4</td><td align="left">3.6</td><td align="left">NS</td></tr><tr><td align="left">hsa00020</td><td align="left">Citrate cycle (TCA cycle)</td><td align="left">20</td><td align="left">2.36</td><td align="left">0.003</td><td align="left">4</td><td align="left">5.1</td><td align="left">NS</td></tr><tr><td align="left">hsa04120</td><td align="left">Ubiquitin mediated proteolysis</td><td align="left">55</td><td align="left">1.49</td><td align="left">0.016</td><td align="left">2</td><td align="left">0.6</td><td align="left">NS</td></tr><tr><td colspan="8"><hr/></td></tr><tr><td align="left">hsa00071</td><td align="left">Fatty acid metabolism</td><td align="left">24</td><td align="left">1.89</td><td align="left">0.017</td><td align="left">2</td><td align="left">1.7</td><td align="left">NS</td></tr><tr><td colspan="8"><hr/></td></tr><tr><td align="left">GO CC:0005681</td><td align="left">spliceosome</td><td align="left">78</td><td align="left">2.71</td><td align="left">2.04 &#x000d7; 10<sup>-18</sup></td><td align="left">1</td><td align="left">0.7</td><td align="left">NS</td></tr><tr><td align="left">hsa03050</td><td align="left">Proteasome</td><td align="left">21</td><td align="left">3.38</td><td align="left">2.28 &#x000d7; 10<sup>-07</sup></td><td align="left">1</td><td align="left">1.7</td><td align="left">NS</td></tr></tbody></table><table-wrap-foot><p>GO categories and KEGG pathways overrepresented among genes expressed in equine skeletal muscle compared to all annotated equine genes. Terms in italics are more significantly overrepresented among the high abundance genes. High abundance genes are defined as those comprising &#x0003e; 0.05% of annotated muscle transcriptome. FC - fold change; Adj P - adjusted <italic>P </italic>value using the Benjamini and Hochberg method.</p></table-wrap-foot></table-wrap><p>A list of the most abundant genes (those comprising &#x0003e;0.5% of annotated muscle transcriptome) is presented in Table <xref ref-type="table" rid="T2">2</xref>. Just 28 genes contribute to over 50% of the annotated mRNA in equine skeletal muscle and are principally involved in muscle contraction and energy metabolism. Creatine kinase muscle (<italic>CKM</italic>) was the most abundantly expressed gene in equine skeletal muscle representing 6.9% of the annotated transcriptome and creatine kinase, mitochondrial 2, (<italic>CKMT2</italic>), was ranked 20<sup>th </sup>among the most abundantly expressed genes, making up 0.8% of the transcriptome. Human studies using SAGE have indicated that <italic>CKM </italic>mRNA makes up ~1% of the human skeletal muscle transcriptome and <italic>CKMT2 </italic>did not feature in a list of the 54 most abundantly expressed genes [<xref ref-type="bibr" rid="B56">56</xref>]. The very high levels of both isoforms of creatine kinase in equine muscle compared to humans is indicative of the highly adapted athletic capacity of Thoroughbred horses as creatine kinases play a crucial role as an energy store in tissues with fluctuating energy demands. CKM is utilised during anaerobic respiration while CKMT2 is tightly coupled to oxidative phosphorylation [<xref ref-type="bibr" rid="B57">57</xref>-<xref ref-type="bibr" rid="B60">60</xref>]. The importance of CKM in athletic adaptation in the horse is further supported by the identification of a novel SNP in the <italic>CKM </italic>gene that, in a preliminary study, has been observed to be associated with racing performance [<xref ref-type="bibr" rid="B61">61</xref>]. The third most highly expressed gene in equine skeletal muscle, actin, alpha 1, skeletal muscle (<italic>ACTA1</italic>) has also been implicated as a candidate athletic performance gene following a genome scan for positive selection in Thoroughbred horses [<xref ref-type="bibr" rid="B62">62</xref>].</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Highly abundant transcripts in equine skeletal muscle</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Gene symbol</th><th align="left">Gene name</th><th align="left">Total reads</th><th align="left">% All</th><th align="left">Cumulative %</th><th align="left">Average no. reads pre-training</th><th align="left">% All</th><th align="left">Average no. reads post training</th><th align="left">% All</th></tr></thead><tbody><tr><td align="left"><italic>CKM</italic></td><td align="left">Creatine kinase, muscle</td><td align="left">236,942</td><td align="left">6.9</td><td align="left">6.9</td><td align="left">18,642</td><td align="left">6.7</td><td align="left">17,870</td><td align="left">7.1</td></tr><tr><td align="left"><italic>MYL1</italic></td><td align="left">Myosin, light polypeptide 1, alkali; skeletal, fast</td><td align="left">203,634</td><td align="left">5.9</td><td align="left">12.8</td><td align="left">17,454</td><td align="left">6.2</td><td align="left">14,130</td><td align="left">5.6</td></tr><tr><td align="left"><italic>ACTA1</italic></td><td align="left">Actin, alpha 1, skeletal muscle</td><td align="left">147,884</td><td align="left">4.3</td><td align="left">17.1</td><td align="left">15,065</td><td align="left">5.4</td><td align="left">8,214</td><td align="left">3.3</td></tr><tr><td align="left"><italic>TNNC2</italic></td><td align="left">Troponin C type 2 (fast)</td><td align="left">147,779</td><td align="left">4.3</td><td align="left">21.4</td><td align="left">12,128</td><td align="left">4.3</td><td align="left">10,716</td><td align="left">4.2</td></tr><tr><td align="left"><italic>ALDOA</italic></td><td align="left">Aldolase A, fructose-bisphosphate</td><td align="left">118,636</td><td align="left">3.4</td><td align="left">24.8</td><td align="left">9,506</td><td align="left">3.4</td><td align="left">8,800</td><td align="left">3.5</td></tr><tr><td align="left"><italic>TTN</italic></td><td align="left">Titin</td><td align="left">116,385</td><td align="left">3.4</td><td align="left">28.2</td><td align="left">9,919</td><td align="left">3.5</td><td align="left">8,125</td><td align="left">3.2</td></tr><tr><td align="left"><italic>MYLPF</italic></td><td align="left">Myosin light chain, phosphorylatable, fast skeletal muscle</td><td align="left">97,094</td><td align="left">2.8</td><td align="left">31.0</td><td align="left">7,426</td><td align="left">2.7</td><td align="left">7,506</td><td align="left">3.0</td></tr><tr><td align="left"><italic>MYH1</italic></td><td align="left">Myosin, heavy polypeptide 1, skeletal muscle, adult</td><td align="left">91,271</td><td align="left">2.7</td><td align="left">33.7</td><td align="left">8,611</td><td align="left">3.1</td><td align="left">5,658</td><td align="left">2.2</td></tr><tr><td align="left"><italic>TPM2</italic></td><td align="left">Tropomyosin 2 (beta)</td><td align="left">73,395</td><td align="left">2.1</td><td align="left">35.8</td><td align="left">6,240</td><td align="left">2.2</td><td align="left">5,136</td><td align="left">2.0</td></tr><tr><td align="left"><italic>ATP2A1</italic></td><td align="left">ATPase, Ca++ transporting, cardiac muscle, fast twitch 1</td><td align="left">59,889</td><td align="left">1.7</td><td align="left">37.6</td><td align="left">5,516</td><td align="left">2.0</td><td align="left">3,827</td><td align="left">1.5</td></tr><tr><td align="left"><italic>RPLP1P4</italic></td><td align="left">Ribosomal protein, large, P1 pseudogene 4</td><td align="left">55,290</td><td align="left">1.6</td><td align="left">39.2</td><td align="left">4,340</td><td align="left">1.6</td><td align="left">4,178</td><td align="left">1.7</td></tr><tr><td align="left"><italic>ENO3</italic></td><td align="left">Enolase 3 (beta, muscle)</td><td align="left">40,827</td><td align="left">1.2</td><td align="left">40.4</td><td align="left">3,143</td><td align="left">1.1</td><td align="left">3,138</td><td align="left">1.2</td></tr><tr><td align="left"><italic>LOC440359</italic></td><td align="left">Similar to cold shock domain protein A short isoform</td><td align="left">36,681</td><td align="left">1.1</td><td align="left">41.4</td><td align="left">2,877</td><td align="left">1.0</td><td align="left">2,774</td><td align="left">1.1</td></tr><tr><td align="left"><italic>ATP5O</italic></td><td align="left">ATP synthase, H+ transporting, mitochondrial f1 complex, o subunit</td><td align="left">34,234</td><td align="left">1.0</td><td align="left">42.4</td><td align="left">2,212</td><td align="left">0.8</td><td align="left">2,994</td><td align="left">1.2</td></tr><tr><td align="left"><italic>MYOZ1</italic></td><td align="left">MYOZENIN 1</td><td align="left">32,638</td><td align="left">0.9</td><td align="left">43.4</td><td align="left">2,449</td><td align="left">0.9</td><td align="left">2,564</td><td align="left">1.0</td></tr><tr><td align="left"><italic>PYGM</italic></td><td align="left">Phosphorylase, glycogen; muscle</td><td align="left">31,710</td><td align="left">0.9</td><td align="left">44.3</td><td align="left">2,895</td><td align="left">1.0</td><td align="left">2,048</td><td align="left">0.8</td></tr><tr><td align="left"><italic>TPM1</italic></td><td align="left">Tropomyosin 1 (alpha)</td><td align="left">30,823</td><td align="left">0.9</td><td align="left">45.2</td><td align="left">2,820</td><td align="left">1.0</td><td align="left">1,986</td><td align="left">0.8</td></tr><tr><td align="left"><italic>MYBPC2</italic></td><td align="left">Myosin binding protein C, fast type</td><td align="left">28,386</td><td align="left">0.8</td><td align="left">46.0</td><td align="left">2,409</td><td align="left">0.9</td><td align="left">1,990</td><td align="left">0.8</td></tr><tr><td align="left"><italic>TNNT3</italic></td><td align="left">Troponin t type 3 (skeletal, fast)</td><td align="left">27,469</td><td align="left">0.8</td><td align="left">46.8</td><td align="left">1,960</td><td align="left">0.7</td><td align="left">2,244</td><td align="left">0.9</td></tr><tr><td align="left"><italic>CKMT2</italic></td><td align="left">Creatine kinase, mitochondrial 2 (sarcomeric)</td><td align="left">27,394</td><td align="left">0.8</td><td align="left">47.6</td><td align="left">1,622</td><td align="left">0.6</td><td align="left">2,523</td><td align="left">1.0</td></tr><tr><td align="left"><italic>TNNI2</italic></td><td align="left">Troponin I type 2 (skeletal, fast)</td><td align="left">25,005</td><td align="left">0.7</td><td align="left">48.3</td><td align="left">1,674</td><td align="left">0.6</td><td align="left">2,138</td><td align="left">0.8</td></tr><tr><td align="left"><italic>PGK1</italic></td><td align="left">Phosphoglycerate kinase 1</td><td align="left">24,378</td><td align="left">0.7</td><td align="left">49.0</td><td align="left">2,005</td><td align="left">0.7</td><td align="left">1,764</td><td align="left">0.7</td></tr><tr><td align="left"><italic>RPL30</italic></td><td align="left">Ribosomal protein L30</td><td align="left">23,575</td><td align="left">0.7</td><td align="left">49.7</td><td align="left">2,162</td><td align="left">0.8</td><td align="left">1,515</td><td align="left">0.6</td></tr><tr><td align="left"><italic>NDUFAB1</italic></td><td align="left">NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8 kDa</td><td align="left">22,285</td><td align="left">0.6</td><td align="left">50.4</td><td align="left">1,570</td><td align="left">0.6</td><td align="left">1,838</td><td align="left">0.7</td></tr><tr><td align="left"><italic>SLC25A4</italic></td><td align="left">Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4</td><td align="left">21,881</td><td align="left">0.6</td><td align="left">51.0</td><td align="left">1,270</td><td align="left">0.5</td><td align="left">2,037</td><td align="left">0.8</td></tr><tr><td align="left"><italic>ACTN3</italic></td><td align="left">Actinin, alpha 3</td><td align="left">21,097</td><td align="left">0.6</td><td align="left">51.6</td><td align="left">2,042</td><td align="left">0.7</td><td align="left">1,264</td><td align="left">0.5</td></tr><tr><td align="left"><italic>PGAM2</italic></td><td align="left">Phosphoglycerate mutase 2 (muscle)</td><td align="left">21,059</td><td align="left">0.6</td><td align="left">52.2</td><td align="left">1,736</td><td align="left">0.6</td><td align="left">1,521</td><td align="left">0.6</td></tr><tr><td align="left"><italic>RPS13</italic></td><td align="left">Ribosomal protein S13</td><td align="left">19,063</td><td align="left">0.6</td><td align="left">52.8</td><td align="left">1,610</td><td align="left">0.6</td><td align="left">1,343</td><td align="left">0.5</td></tr></tbody></table></table-wrap></sec><sec><title>Differential gene expression following training</title><p>Following correction for multiple testing, a total of 92 transcripts were significantly (FDR = 0.05) differentially expressed in the skeletal muscle transcriptome following a ten month period of training: nineteen transcripts showed increased expression (+0.72-fold to +29.3-fold), and 73 displayed decreased expression (-0.43-fold to -4.2-fold). Twenty of the differentially expressed transcripts lay within annotated genes, 54 transcripts were located &#x0003c; 5 kb up or downstream of annotated genes and for 18 transcripts no annotated genes were located within 5 kb. The transcripts located in the vicinity of equine genes may represent regulatory regions of the genes and more in-depth analysis and annotation of the recently sequenced equine genome may lead to a reassessment of the boundaries of many currently annotated genes [<xref ref-type="bibr" rid="B63">63</xref>]. The uncharacterised transcripts that were not in the region of any known equine gene may represent novel equine exercise related genes or non-protein coding regulatory mRNAs. The differentially expressed transcripts, including those located within 5 kb of a known gene, and the associated gene names are listed in Table <xref ref-type="table" rid="T3">3</xref> and Table <xref ref-type="table" rid="T4">4</xref>.</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Genes significantly up-regulated post-training compared to pre-training levels</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Tag</th><th align="left">Gene symbol</th><th align="left">Gene name</th><th align="left">FC</th><th align="left">Adj <italic>P</italic></th></tr></thead><tbody><tr><td align="left">gctgctctgcagtctga</td><td align="left"><italic>ACADVL</italic></td><td align="left">Acyl-Coenzyme A dehydrogenase, very long chain</td><td align="left">0.72</td><td align="left">0.037</td></tr><tr><td align="left">gaataattgaagactgg</td><td align="left"><italic>ACTR3B</italic></td><td align="left">Arp3 Actin-Related Protein 3 Homolog B</td><td align="left">2.37</td><td align="left">0.041</td></tr><tr><td align="left">gcgtccttgaggtccgg</td><td align="left"><italic>C14orf153*</italic></td><td align="left">Chromosome 14 open reading frame 153</td><td align="left">1.14</td><td align="left">0.049</td></tr><tr><td align="left">ctgtttttctgtttttt</td><td align="left"><italic>CUL3*</italic></td><td align="left">Cullin 3</td><td align="left">1.43</td><td align="left">0.004</td></tr><tr><td align="left">tgataccaatattcagt</td><td align="left"><italic>FBXO32*</italic></td><td align="left">F-box protein 32</td><td align="left">1.17</td><td align="left">0.009</td></tr><tr><td align="left">cagaaagagcagggaag</td><td align="left"><italic>GOT1*</italic></td><td align="left">Glutamic-oxaloacetic transaminase 1, soluble</td><td align="left">1.46</td><td align="left">0.035</td></tr><tr><td align="left">tggatgtgtggctatgg</td><td align="left"><italic>GRHPR</italic></td><td align="left">Glyoxylate Reductase/Hydroxypyruvate Reductase</td><td align="left">1.45</td><td align="left">0.043</td></tr><tr><td align="left">ggacccatgaaggacca</td><td align="left"><italic>IGFN1*</italic></td><td align="left">Immunoglobulin-like and fibronectin type III domain-containing protein 1</td><td align="left">2.03</td><td align="left">0.019</td></tr><tr><td align="left">tggttctgtttgttttg</td><td align="left"><italic>KIAA1303*</italic></td><td align="left">P150 target of rapamycin (TOR)-scaffold protein</td><td align="left">2.70</td><td align="left">0.049</td></tr><tr><td align="left">gagtgcagcctttcacc</td><td align="left"><italic>MRPS21</italic></td><td align="left">28 S ribosomal protein S21, mitochondrial</td><td align="left">3.24</td><td align="left">0.024</td></tr><tr><td align="left">accagagagatgaatgt</td><td align="left"><italic>MRPS21</italic></td><td align="left">28 S ribosomal protein S21, mitochondrial</td><td align="left">1.76</td><td align="left">0.032</td></tr><tr><td align="left">tgttgaagcgatgcagt</td><td align="left"><italic>PER2*</italic></td><td align="left">Period homolog 2</td><td align="left">29.26</td><td align="left">0.004</td></tr><tr><td align="left">tgttggtaagtagatcg</td><td align="left"><italic>PER3*</italic></td><td align="left">Period homolog 3 (Drosophila)</td><td align="left">1.05</td><td align="left">0.047</td></tr><tr><td align="left">tggctgtatggggaggc</td><td align="left"><italic>SLC25A29*</italic></td><td align="left">Solute carrier family 25 member 29</td><td align="left">1.32</td><td align="left">0.013</td></tr><tr><td align="left">gccttctgcacccagaa</td><td align="left"><italic>TNNT3*</italic></td><td align="left">Troponin T Type 3 (Skeletal, Fast)</td><td align="left">1.55</td><td align="left">0.002</td></tr><tr><td align="left">ttaaatatacttggaag</td><td align="left"><italic>ZAK*</italic></td><td align="left">Sterile alpha motif and leucine zipper containing kinase AZK</td><td align="left">2.08</td><td align="left">0.023</td></tr></tbody></table><table-wrap-foot><p>An asterisk (*) indicates that the tag lay within 5 kb of the gene. FC - fold change; Adj P - adjusted <italic>P </italic>value using the Benjamini and Hochberg method.</p></table-wrap-foot></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Genes significantly down-regulated post-training compared to pre-training levels</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Tag</th><th align="left">Gene Symbol</th><th align="left">Gene Name</th><th align="left">FC</th><th align="left">Adj <italic>P</italic></th></tr></thead><tbody><tr><td align="left">acccgagagacagccga</td><td align="left"><italic>ACTN3</italic></td><td align="left">actinin, alpha 3</td><td align="left">-0.97</td><td align="left">0.029</td></tr><tr><td align="left">acacagttagttaattt</td><td align="left"><italic>AHCYL2*</italic></td><td align="left">Putative adenosylhomocysteinase 3</td><td align="left">-1.39</td><td align="left">0.006</td></tr><tr><td align="left">acacagttagttaattt</td><td align="left"><italic>AHCYL2*</italic></td><td align="left">Putative adenosylhomocysteinase 3</td><td align="left">-1.39</td><td align="left">0.006</td></tr><tr><td align="left">taattttatttttttta</td><td align="left"><italic>ANKHD1*</italic></td><td align="left">Ankyrin repeat and KH domain containing 1</td><td align="left">-2.30</td><td align="left">0.043</td></tr><tr><td align="left">ttttccctcacatcttc</td><td align="left"><italic>APOOL*</italic></td><td align="left">Apolipoprotein O-like</td><td align="left">-0.54</td><td align="left">0.003</td></tr><tr><td align="left">cttagtgtgtatatctc</td><td align="left"><italic>ATP2B1</italic></td><td align="left">ATPase, Ca++ transporting, plasma membrane 1</td><td align="left">-0.62</td><td align="left">0.041</td></tr><tr><td align="left">atcattattttaccttt</td><td align="left"><italic>BCL6*</italic></td><td align="left">B-cell CLL/lymphoma 6</td><td align="left">-3.09</td><td align="left">0.011</td></tr><tr><td align="left">acggttttccccagatc</td><td align="left"><italic>C1orf51*</italic></td><td align="left">Chromosome 1 open reading frame 51</td><td align="left">-1.61</td><td align="left">0.035</td></tr><tr><td align="left">cactggccaaaagattt</td><td align="left"><italic>C21orf7</italic></td><td align="left">Chromosome 21 open reading frame 7</td><td align="left">-3.08</td><td align="left">0.035</td></tr><tr><td align="left">ccactaccctcttactc</td><td align="left"><italic>CALM3*</italic></td><td align="left">Calmodulin3</td><td align="left">-1.46</td><td align="left">0.009</td></tr><tr><td align="left">acagacacttggctaaa</td><td align="left"><italic>CALM3*</italic></td><td align="left">Calmodulin3</td><td align="left">-0.83</td><td align="left">0.043</td></tr><tr><td align="left">aacagaatcaaggagct</td><td align="left"><italic>CCNDBP1</italic></td><td align="left">Cyclin-D1-binding protein 1</td><td align="left">-0.81</td><td align="left">0.035</td></tr><tr><td align="left">gaaaacagtagctaaag</td><td align="left"><italic>DAG1</italic></td><td align="left">dystroglycan 1</td><td align="left">-1.49</td><td align="left">0.022</td></tr><tr><td align="left">ctcaacagcaacatcaa</td><td align="left"><italic>EIF3F</italic></td><td align="left">Eukaryotic translation initiation factor 3, subunit F</td><td align="left">-0.52</td><td align="left">0.002</td></tr><tr><td align="left">tccagcctcaaagcatt</td><td align="left"><italic>FBXL17*</italic></td><td align="left">F-Box And Leucine-Rich Repeat Protein 17</td><td align="left">-0.52</td><td align="left">0.002</td></tr><tr><td align="left">aactgtagtgctttaaa</td><td align="left"><italic>GATM</italic></td><td align="left">Glycine Amidinotransferase</td><td align="left">-1.35</td><td align="left">0.035</td></tr><tr><td align="left">taggttttacctccatt</td><td align="left"><italic>GATM*</italic></td><td align="left">Glycine Amidinotransferase</td><td align="left">-1.35</td><td align="left">0.001</td></tr><tr><td align="left">ctggaacaggggcgaac</td><td align="left"><italic>GLUL*</italic></td><td align="left">Glutamate-ammonia ligase</td><td align="left">-3.94</td><td align="left">0.007</td></tr><tr><td align="left">cccatcatccccttcct</td><td align="left"><italic>GPSN2</italic></td><td align="left">GLYCOPROTEIN, SYNAPTIC 2</td><td align="left">-1.06</td><td align="left">0.004</td></tr><tr><td align="left">aagtcccaccccaatat</td><td align="left"><italic>GSTM5*</italic></td><td align="left">Glutathione S-transferase M5</td><td align="left">-1.1</td><td align="left">0.004</td></tr><tr><td align="left">tccacccataagcagat</td><td align="left"><italic>HOXC9*</italic></td><td align="left">Homeobox protein Hox-C9</td><td align="left">-1.04</td><td align="left">0.038</td></tr><tr><td align="left">ggactgtctttattttt</td><td align="left"><italic>IGFBP5*</italic></td><td align="left">Insulin-like growth factor binding protein-5</td><td align="left">-2.32</td><td align="left">0.001</td></tr><tr><td align="left">gtaaccctacacagtca</td><td align="left"><italic>IGFBP5*</italic></td><td align="left">Insulin-like growth factor binding protein-5</td><td align="left">-2.12</td><td align="left">0.038</td></tr><tr><td align="left">cccagaaagacatttgt</td><td align="left"><italic>IRF2BP2*</italic></td><td align="left">Interferon regulatory factor 2 binding protein 2</td><td align="left">-1.57</td><td align="left">0.001</td></tr><tr><td align="left">caaaaggctctcctaat</td><td align="left"><italic>KCMF1</italic></td><td align="left">potassium channel modulatory factor 1</td><td align="left">-0.81</td><td align="left">0.048</td></tr><tr><td align="left">tttccattcaacaaaaa</td><td align="left"><italic>KPNA1*</italic></td><td align="left">Karyopherin alpha 1</td><td align="left">-1.8</td><td align="left">0.006</td></tr><tr><td align="left">aattactctttcactgt</td><td align="left"><italic>KPNA3*</italic></td><td align="left">Karyopherin alpha 3</td><td align="left">-1.55</td><td align="left">0.043</td></tr><tr><td align="left">cttttcacacacaaaac</td><td align="left"><italic>LRRFIP1*</italic></td><td align="left">Leucine Rich Repeat</td><td align="left">-0.95</td><td align="left">4.1 &#x000d7; 10<sup>-5</sup></td></tr><tr><td align="left">ttaagtgccattactac</td><td align="left"><italic>MAP3K4</italic></td><td align="left">Mitogen-activated protein kinase kinase kinase 4</td><td align="left">-0.85</td><td align="left">0.048</td></tr><tr><td align="left">ccccaccctactcccac</td><td align="left"><italic>MLEC*</italic></td><td align="left">Malectin</td><td align="left">-1.13</td><td align="left">0.017</td></tr><tr><td align="left">tatgacagaaaagcaac</td><td align="left"><italic>MSTN*</italic></td><td align="left">Myostatin</td><td align="left">-2.56</td><td align="left">0.002</td></tr><tr><td align="left">atgactgtataatgtga</td><td align="left"><italic>MSTN*</italic></td><td align="left">Myostatin</td><td align="left">-2.55</td><td align="left">0.008</td></tr><tr><td align="left">gttcctaaataaataat</td><td align="left"><italic>MSTN*</italic></td><td align="left">Myostatin</td><td align="left">-4.2</td><td align="left">0.004</td></tr><tr><td align="left">ctgctgagcggcctctc</td><td align="left"><italic>MYLK2</italic></td><td align="left">Myosin Light Chain Kinase 2, Skeletal Muscle</td><td align="left">-1.94</td><td align="left">0.034</td></tr><tr><td align="left">gctcattaaagaacaaa</td><td align="left"><italic>MYO9A*</italic></td><td align="left">Myosin Ixa</td><td align="left">-1.03</td><td align="left">0.043</td></tr><tr><td align="left">ctatcttttccttttct</td><td align="left"><italic>NAT12*</italic></td><td align="left">N-acetyltransferase MAK3 homolog</td><td align="left">-0.68</td><td align="left">0.002</td></tr><tr><td align="left">attgtttaaatatcact</td><td align="left"><italic>NEDD4*</italic></td><td align="left">Neural precursor cell expressed, developmentally down-regulated 4</td><td align="left">-0.97</td><td align="left">0.012</td></tr><tr><td align="left">aaatcccaccctcccct</td><td align="left"><italic>NLN*</italic></td><td align="left">Neurolysin</td><td align="left">-1.02</td><td align="left">0.008</td></tr><tr><td align="left">tccagctttctattctt</td><td align="left"><italic>PALLD*</italic></td><td align="left">Palladin, cytoskeletal associated protein</td><td align="left">-1.06</td><td align="left">0.039</td></tr><tr><td align="left">cttctttccccacctcc</td><td align="left"><italic>PCBP4</italic></td><td align="left">Poly(rC) binding protein 4</td><td align="left">-0.82</td><td align="left">0.004</td></tr><tr><td align="left">taattgcagtttactat</td><td align="left"><italic>GNPNAT1*</italic></td><td align="left">Similar to glucosamine-phosphate N-acetyltransferase 1</td><td align="left">-1.23</td><td align="left">0.006</td></tr><tr><td align="left">ctctagaacatttacct</td><td align="left"><italic>PTDSS1*</italic></td><td align="left">Phosphatidylserine synthase 1</td><td align="left">-0.62</td><td align="left">0.003</td></tr><tr><td align="left">agagtcaatataaaggt</td><td align="left"><italic>PTPLA*</italic></td><td align="left">Protein Tyrosine Phosphatase-Like</td><td align="left">-2.07</td><td align="left">0.01</td></tr><tr><td align="left">aaatctaaagttaaata</td><td align="left"><italic>RAB33B*</italic></td><td align="left">RAB33B, member RAS oncogene family</td><td align="left">-1.24</td><td align="left">0.04</td></tr><tr><td align="left">cagccctgggggcctac</td><td align="left"><italic>RYK</italic></td><td align="left">Ryk Receptor-Like Tyrosine Kinase</td><td align="left">-0.94</td><td align="left">0.005</td></tr><tr><td align="left">attcccatttctagtaa</td><td align="left"><italic>SEPT7*</italic></td><td align="left">Transcribed locus</td><td align="left">-0.72</td><td align="left">0.018</td></tr><tr><td align="left">tgaggacaaagctcagg</td><td align="left"><italic>SLC10A2*</italic></td><td align="left">Solute carrier family 10</td><td align="left">-4.11</td><td align="left">0.001</td></tr><tr><td align="left">ccttcaactcaacaaat</td><td align="left"><italic>SNAP29*</italic></td><td align="left">Synaptosomal-associated protein, 29 kDa</td><td align="left">-0.43</td><td align="left">0.009</td></tr><tr><td align="left">gtattgtaagatattaa</td><td align="left"><italic>SNORA24*</italic></td><td align="left">Small nucleolar RNA SNORA24</td><td align="left">-0.89</td><td align="left">0.037</td></tr><tr><td align="left">aagcaagaaataaattt</td><td align="left"><italic>TET1*</italic></td><td align="left">Tet oncogene 1</td><td align="left">-1.4</td><td align="left">0.029</td></tr><tr><td align="left">atgcagagcaccacaga</td><td align="left"><italic>TLE1</italic></td><td align="left">transducin-like enhancer of split 1</td><td align="left">-1.58</td><td align="left">2.0 &#x000d7; 10<sup>-5</sup></td></tr><tr><td align="left">actgacatatgtaaaga</td><td align="left"><italic>TOR3A*</italic></td><td align="left">torsin family 3, member A</td><td align="left">-1.49</td><td align="left">0.022</td></tr><tr><td align="left">tgcctatcacctgccgg</td><td align="left"><italic>TPD52*</italic></td><td align="left">Tumor protein D52</td><td align="left">-0.68</td><td align="left">0.005</td></tr><tr><td align="left">tcctttcagtcttcaca</td><td align="left"><italic>TSPAN3</italic></td><td align="left">Tetraspanin 3</td><td align="left">-0.58</td><td align="left">0.04</td></tr><tr><td align="left">ctttgtgacttccaagt</td><td align="left"><italic>ULK2*</italic></td><td align="left">Unc-51-like kinase 2</td><td align="left">-0.72</td><td align="left">0.018</td></tr><tr><td align="left">aaaccatatttcttccc</td><td align="left"><italic>VCL*</italic></td><td align="left">Vinculin</td><td align="left">-1.13</td><td align="left">0.005</td></tr><tr><td align="left">cccaggcccgtccctgc</td><td align="left"><italic>ZC3H3*</italic></td><td align="left">Zinc finger CCCH-type containing 3</td><td align="left">-1.28</td><td align="left">0.035</td></tr><tr><td align="left">aagtctaacttccattt</td><td align="left"><italic>ZNF704*</italic></td><td align="left">Zinc finger protein 704</td><td align="left">-0.93</td><td align="left">0.013</td></tr><tr><td align="left">ttagtttcttttcttta</td><td align="left"><italic>ZWINT*</italic></td><td align="left">ZW10 interactor</td><td align="left">-1.21</td><td align="left">1.1 &#x000d7; 10<sup>-4</sup></td></tr></tbody></table><table-wrap-foot><p>An asterisk (*) indicates that the tag lay within 5 kb of the gene. FC - fold change; Adj P - adjusted <italic>P </italic>value using the Benjamini and Hochberg method.</p></table-wrap-foot></table-wrap><p>Genes with higher post-training basal mRNA levels included those involved in the mitochondria, ubiquitination and circadian rhythm regulation, whereas genes with significantly reduced mRNA were mainly associated with cytoskeletal structure and the control of growth and development.</p></sec><sec><title>Functional profiling of differentially expressed genes</title><p>Significantly up and down-regulated blocks of functionally related genes were identified by performing a gene enrichment test (FatiScan) for all expressed genes ranked according to differential expression following training. Among the up-regulated genes we identified 275 significantly (FDR &#x0003c; 0.05) overrepresented GO terms and 13 KEGG pathways. Among the down-regulated genes we identified 207 significantly (FDR &#x0003c; 0.05) overrepresented GO terms and five KEGG pathways. Subsets of the functional groups are shown in Table <xref ref-type="table" rid="T5">5</xref> and Table <xref ref-type="table" rid="T6">6</xref>, and were chosen to include all significant (FDR&#x0003c;0.05) KEGG pathways and all highly significantly (FDR &#x0003c; 0.0001) overrepresented functional groups satisfying GO &#x0003e; level 6 and for which at least six genes were identified.</p><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Gene ontology categories with significantly increased expression post-training compared to pre-training levels</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">GO ID</th><th align="left">GO Term</th><th align="left"><italic>P</italic></th></tr></thead><tbody><tr><td align="left">BP:0009060</td><td align="left">aerobic respiration</td><td align="left">1.89 &#x000d7; 10<sup>-16</sup></td></tr><tr><td align="left">BP:0046356</td><td align="left">acetyl-CoA catabolic process</td><td align="left">2.28 &#x000d7; 10<sup>-16</sup></td></tr><tr><td align="left">BP:0006099</td><td align="left">tricarboxylic acid cycle</td><td align="left">5.83 &#x000d7; 10<sup>-16</sup></td></tr><tr><td align="left">BP:0006100</td><td align="left">tricarboxylic acid cycle intermediate metabolic process</td><td align="left">5.92 &#x000d7; 10<sup>-10</sup></td></tr><tr><td align="left">BP:0019395</td><td align="left">fatty acid oxidation</td><td align="left">4.65 &#x000d7; 10<sup>-08</sup></td></tr><tr><td align="left">BP:0006119</td><td align="left">oxidative phosphorylation</td><td align="left">3.69 &#x000d7; 10<sup>-06</sup></td></tr><tr><td align="left">BP:0006956</td><td align="left">complement activation</td><td align="left">4.07 &#x000d7; 10<sup>-06</sup></td></tr><tr><td align="left">BP:0002455</td><td align="left">humoral immune response mediated by circulating immunoglobulin</td><td align="left">4.07 &#x000d7; 10<sup>-06</sup></td></tr><tr><td align="left">BP:0002253</td><td align="left">activation of immune response</td><td align="left">5.31 &#x000d7; 10<sup>-06</sup></td></tr><tr><td align="left">BP:0006635</td><td align="left">fatty acid beta-oxidation</td><td align="left">6.70 &#x000d7; 10<sup>-06</sup></td></tr><tr><td align="left">BP:0002541</td><td align="left">activation of plasma proteins during acute inflammatory response</td><td align="left">8.46 &#x000d7; 10<sup>-06</sup></td></tr><tr><td align="left">BP:0050778</td><td align="left">positive regulation of immune response</td><td align="left">8.46 &#x000d7; 10<sup>-06</sup></td></tr><tr><td align="left">BP:0006631</td><td align="left">fatty acid metabolic process</td><td align="left">7.12 &#x000d7; 10<sup>-05</sup></td></tr><tr><td align="left">CC:0005739</td><td align="left">mitochondrion</td><td align="left">1.04 &#x000d7; 10<sup>-41</sup></td></tr><tr><td align="left">CC:0043231</td><td align="left">intracellular membrane-bound organelle</td><td align="left">8.17 &#x000d7; 10<sup>-21</sup></td></tr><tr><td align="left">CC:0019866</td><td align="left">organelle inner membrane</td><td align="left">2.16 &#x000d7; 10<sup>-19</sup></td></tr><tr><td align="left">CC:0044429</td><td align="left">mitochondrial part</td><td align="left">1.04 &#x000d7; 10<sup>-16</sup></td></tr><tr><td align="left">CC:0044444</td><td align="left">cytoplasmic part</td><td align="left">6.14 &#x000d7; 10<sup>-16</sup></td></tr><tr><td align="left">CC:0031967</td><td align="left">organelle envelope</td><td align="left">1.07 &#x000d7; 10<sup>-08</sup></td></tr><tr><td align="left">CC:0031090</td><td align="left">organelle membrane</td><td align="left">2.25 &#x000d7; 10<sup>-05</sup></td></tr><tr><td align="left">CC:0000793</td><td align="left">condensed chromosome</td><td align="left">5.40 &#x000d7; 10<sup>-05</sup></td></tr><tr><td align="left">CC:0005840</td><td align="left">ribosome</td><td align="left">7.74 &#x000d7; 10<sup>-05</sup></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left"><bold>KEGG ID</bold></td><td align="left"><bold>KEGG pathway</bold></td><td align="left"/></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left">hsa04510</td><td align="left">Complement and coagulation cascades</td><td align="left">5.61 &#x000d7; 10<sup>-06</sup></td></tr><tr><td align="left">has00750</td><td align="left">Vitamin B6 metabolism</td><td align="left">1.21 &#x000d7; 10<sup>-04</sup></td></tr><tr><td align="left">hsa00790</td><td align="left">Folate biosynthesis</td><td align="left">1.35 &#x000d7; 10<sup>-04</sup></td></tr><tr><td align="left">hsa00350</td><td align="left">Tyrosine metabolism</td><td align="left">3.93 &#x000d7; 10<sup>-04</sup></td></tr><tr><td align="left">hsa00760</td><td align="left">Nicotinate and nicotinamide metabolism</td><td align="left">4.51 &#x000d7; 10<sup>-04</sup></td></tr><tr><td align="left">hsa00020</td><td align="left">Citrate cycle (TCA cycle)</td><td align="left">0.002</td></tr><tr><td align="left">hsa00190</td><td align="left">Oxidative phosphorylation</td><td align="left">0.002</td></tr><tr><td align="left">hsa00500</td><td align="left">Starch and sucrose metabolism</td><td align="left">0.002</td></tr><tr><td align="left">hsa00280</td><td align="left">Valine, leucine and isoleucine degradation</td><td align="left">0.003</td></tr><tr><td align="left">hsa00380</td><td align="left">Tryptophan metabolism</td><td align="left">0.003</td></tr><tr><td align="left">has00720</td><td align="left">Reductive carboxylate cycle (CO2 fixation)</td><td align="left">0.007</td></tr><tr><td align="left">hsa00860</td><td align="left">Porphyrin and chlorophyll metabolism</td><td align="left">0.019</td></tr><tr><td align="left">hsa00252</td><td align="left">Alanine and aspartate metabolism</td><td align="left">0.032</td></tr></tbody></table></table-wrap><table-wrap id="T6" position="float"><label>Table 6</label><caption><p>Gene ontology categories with significantly decreased expression post-training compared to pre-training levels</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">GO ID</th><th align="left">GO Term</th><th align="left"><italic>P</italic></th></tr></thead><tbody><tr><td align="left">BP:0006817</td><td align="left">phosphate transport</td><td align="left">2.92 &#x000d7; 10<sup>-20</sup></td></tr><tr><td align="left">BP:0015698</td><td align="left">inorganic anion transport</td><td align="left">7.84 &#x000d7; 10<sup>-18</sup></td></tr><tr><td align="left">BP:0050679</td><td align="left">positive regulation of epithelial cell proliferation</td><td align="left">9.57 &#x000d7; 10<sup>-05</sup></td></tr><tr><td align="left">CC:0005856</td><td align="left">cytoskeleton</td><td align="left">4.00 &#x000d7; 10<sup>-09</sup></td></tr><tr><td align="left">CC:0044430</td><td align="left">cytoskeletal part</td><td align="left">5.59 &#x000d7; 10<sup>-09</sup></td></tr><tr><td align="left">CC:0016528</td><td align="left">sarcoplasm</td><td align="left">6.32 &#x000d7; 10<sup>-07</sup></td></tr><tr><td align="left">CC:0015629</td><td align="left">actin cytoskeleton</td><td align="left">2.11 &#x000d7; 10<sup>-06</sup></td></tr><tr><td align="left">CC:0016529</td><td align="left">sarcoplasmic reticulum</td><td align="left">2.93 &#x000d7; 10<sup>-06</sup></td></tr><tr><td align="left">CC:0005887</td><td align="left">integral to plasma membrane</td><td align="left">6.96 &#x000d7; 10<sup>-06</sup></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left"><bold>KEGG ID</bold></td><td align="left"><bold>KEGG pathway</bold></td><td align="left"><bold><italic>P</italic></bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left">hsa04530</td><td align="left">Tight junction</td><td align="left">5.30 &#x000d7; 10<sup>-04</sup></td></tr><tr><td align="left">hsa04630</td><td align="left">Jak-STAT signaling pathway</td><td align="left">0.008</td></tr><tr><td align="left">hsa04720</td><td align="left">Long-term potentiation</td><td align="left">0.013</td></tr><tr><td align="left">hsa01430</td><td align="left">Cell communication</td><td align="left">0.032</td></tr><tr><td align="left">hsa04512</td><td align="left">ECM-receptor interaction</td><td align="left">0.046</td></tr></tbody></table></table-wrap><p>The most significantly overrepresented cellular compartment GO groups among the genes with increased abundance post-training were mitochondrion (CC GO:0005739; <italic>P </italic>&#x0003c; 1.04 &#x000d7; 10<sup>-41</sup>) and related terms such as organelle inner membrane (CC GO:0019866) and mitochondrial part (CC GO:0044429). Aerobic respiration (BP GO:0009060), oxidative phosphorylation (BP GO:0006119) and the tricarboxylic acid cycle (GO BP:0006099) were among the overrepresented GO biological processes groups. The KEGG pathways included Citrate cycle (TCA cycle) (hsa00020) and Oxidative phosphorylation (hsa00190) and multiple metabolism pathways. These transcriptional data concur with biochemical and physiological studies that have demonstrated an increase in mitochondrial volume and aerobic capacity following endurance training [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Although there is evidence to indicate that an increase in oxidative capacity is part of the maturation process in horses [<xref ref-type="bibr" rid="B64">64</xref>] it has been demonstrated that exercise training, not growth, causes increases in whole muscle activity of the oxidative enzyme succinate dehydrogynase and changes in muscle fibre type composition in young Thoroughbred horses [<xref ref-type="bibr" rid="B14">14</xref>]. To our knowledge, this is the first time that these GO groups have been shown to have increased expression following exercise training.</p><p>This highlights the value of using a method such as FatiScan which incorporates all experimental data rather than limiting interpretation to those that rank among the highly differentially expressed. Only three mitochondrial genes were among those significantly differentially expressed: <italic>MRPS21</italic>, <italic>SLC25A29 </italic>and <italic>ACADVL</italic>. <italic>MRPS21 </italic>is a nuclear-encoded mitochondrial ribosomal gene required for protein synthesis in the mitochondria. Therefore, an increase in mitochondrial abundance would require an increase in mitochondrial protein synthesis. The <italic>SLC25A29 </italic>and <italic>ACADVL </italic>proteins are localized in the mitochondrial inner membrane and play a role in fat metabolism [<xref ref-type="bibr" rid="B65">65</xref>,<xref ref-type="bibr" rid="B66">66</xref>]. The fatty acid oxidation (BP GO:0019395), fatty acid beta-oxidation (BP GO:0006635) and fatty acid metabolic process (BP GO:0006631) GO ontologies were also overrepresented among genes that increased expression following training. This is in agreement with previous observations of a shift towards fatty acid metabolism in response to exercise training [<xref ref-type="bibr" rid="B3">3</xref>]. Furthermore, 12 of the 13 up-regulated KEGG pathways were associated with aerobic respiration and metabolism. Overall these results demonstrate that exercise training brings about a subtle but coordinated increase in the basal level of gene expression of a wide array of genes involved in energy production and metabolism.</p><p>Interestingly there was also an up-regulation of GO terms involved in the immune response such as the KEGG pathway complement and coagulation cascades, complement activation and positive regulation of immune response. The up-regulation of the complement and coagulation cascades may be a response to exercise induced hemolysis. It has been suggested that exercise induced decreases in blood pH and increases in blood temperature may increase the osmotic fragility of erythrocytes. Previous studies have shown that an immune response is elicited in response to a single bout of exercise and that this response is attenuated in trained subjects. Furthermore, it appears that moderate exercise can enhance the immune response [<xref ref-type="bibr" rid="B67">67</xref>], whereas over-training in humans is detrimental to health and can leave athletes more susceptible to infection [<xref ref-type="bibr" rid="B68">68</xref>]. Overtraining in horses has been associated with increased levels of the alpha-1-antitrypsin protein [<xref ref-type="bibr" rid="B69">69</xref>] which is involved in protection of cells from inflammatory enzymes released from neutrophils [<xref ref-type="bibr" rid="B70">70</xref>]. This protein was also found to be increased in humans following a marathon run but returned to basal levels within a few hours [<xref ref-type="bibr" rid="B71">71</xref>]. Despite numerous studies documenting the immune response to a single bout of exercise [<xref ref-type="bibr" rid="B72">72</xref>-<xref ref-type="bibr" rid="B74">74</xref>], little is known regarding the molecular mechanisms governing the adaptations to the immune response brought about by exercise training. It has been suggested that exercise-induced reactive oxygen species (ROS) may play a major role in the modulation of the immune response following exercise [<xref ref-type="bibr" rid="B75">75</xref>]. It is also likely that exercise-induced muscle damage contributes to the inflammatory response [<xref ref-type="bibr" rid="B76">76</xref>]. The exercise regime undertaken by the horses in this study incorporated both endurance and sprint work which would be expected to elicit both increased ROS and intramuscular microtears.</p><p>Another interesting observation was the increased expression of ribosomal genes as elevated rates of protein synthesis and degradation have been reported following resistance exercise with an overall increase in protein mass [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B77">77</xref>,<xref ref-type="bibr" rid="B78">78</xref>].</p><p>The down-regulated functional groups were mainly associated with structural genes and ion transport. It has been shown that the cellular response to mechanical stimuli, such as increased load, involves ECM signalling to the cytoskeleton at focal adhesion complexes via integrin receptors. Ion transport is central to muscular contraction. Calcium is the main regulatory and signalling molecule in muscle and ATP synthesis is dependent on phosphate transport. Although the down-regulation of these functional groups is counter-intuitive, the modulation of gene expression in these functional groups may reflect structural reorganization of myofibrils.</p></sec><sec><title>Validation of a panel of genes by real time qRT-PCR</title><p>Eleven genes represented by tags that were differentially expressed between untrained and trained skeletal muscle were selected for real time qRT-PCR validation. Four tags (acyl-coenzyme A dehydrogenase, very long chain [<italic>ACADVL</italic>], actinin, alpha 3 [<italic>ACTN3</italic>], dystroglycan 1 [<italic>DAG1</italic>] and 28 S ribosomal protein S21, mitochondrial [<italic>MRPS21</italic>]) were located within a known gene and seven (calmodulin 3 [<italic>CALM3</italic>], insulin-like growth factor binding protein-5 [<italic>IGFPB5</italic>], myostatin [<italic>MSTN</italic>], period homolog 2 [<italic>PER2</italic>], period homolog 3 [<italic>PER3</italic>], solute carrier family 25 member 29 [<italic>SLC25A29</italic>] and troponin T type 3 [<italic>TNNT3</italic>]) were located within 5 kb of a known gene and were predicted to represent the gene. Primers were designed to span exons 1 and 2 or exons 2 and 3 of the gene of interest. This approach was taken to validate both the differential expression of genes and to assess the prediction that the differentially expressed tags that were identified within 5 kb of a known gene were indeed representative transcripts of that gene.</p><p>The mean expression of three of the four genes represented by intergenic tags reached significance (<italic>P </italic>&#x0003c; 0.05) and concurred with DGE data. <italic>ACTN3 </italic>showed the same direction of change as the DGE data and tended towards significance (<italic>P </italic>&#x0003c; 0.1). The mean expression of six of the seven genes predicted to be represented by adjacent tags agreed with the DGE data, the exception being <italic>TNNT3</italic>. The putative <italic>TNNT3 </italic>tag was matched to a region ~880 bp downstream of the <italic>TNNT3 </italic>gene and may represent a novel gene or mRNA. Alternatively the tag may span a splice site in an alternative gene and consequently may represent RNA transcribed from a different region in the genome. Real time qRT-PCR results are detailed in Table <xref ref-type="table" rid="T7">7</xref>.</p><table-wrap id="T7" position="float"><label>Table 7</label><caption><p>Real time qRT-PCR results for genes used to validate DGE data</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Tag</th><th align="left">Gene Symbol</th><th align="left">Gene Name</th><th align="left">DGE FC</th><th align="left">RT-PCR FC</th><th align="left">P</th></tr></thead><tbody><tr><td align="left">gctgctctgcagtctga</td><td align="left"><italic>ACADVL</italic></td><td align="left">Acyl-Coenzyme A dehydrogenase, very long chain</td><td align="left">1.65</td><td align="left">1.72</td><td align="left">0.014</td></tr><tr><td align="left">acccgagagacagccga</td><td align="left"><italic>ACTN3</italic></td><td align="left">Actinin, alpha 3</td><td align="left">-1.97</td><td align="left">-1.41</td><td align="left">NS</td></tr><tr><td align="left">ccactaccctcttactc</td><td align="left"><italic>CALM3</italic></td><td align="left">Calmodulin 3</td><td align="left">-2.75</td><td align="left">-1.81</td><td align="left">0.028</td></tr><tr><td align="left">gaaaacagtagctaaag</td><td align="left"><italic>DAG1</italic></td><td align="left">Dystroglycan 1</td><td align="left">-2.81</td><td align="left">-1.27</td><td align="left">0.021</td></tr><tr><td align="left">ggactgtctttattttt</td><td align="left"><italic>IGFBP5</italic></td><td align="left">Insulin-like growth factor binding protein-5</td><td align="left">-4.35</td><td align="left">-3.18</td><td align="left">0.023</td></tr><tr><td align="left">gagtgcagcctttcacc</td><td align="left"><italic>MRPS21</italic></td><td align="left">28 S ribosomal protein S21, mitochondrial</td><td align="left">9.47</td><td align="left">6.03</td><td align="left">0.013</td></tr><tr><td align="left">tatgacagaaaagcaac</td><td align="left"><italic>MSTN</italic></td><td align="left">Myostatin</td><td align="left">-4.35</td><td align="left">-4.97</td><td align="left">0.004</td></tr><tr><td align="left">tgttgaagcgatgcagt</td><td align="left"><italic>PER2</italic></td><td align="left">Period homolog 2</td><td align="left">+inf</td><td align="left">1.88</td><td align="left">0.003</td></tr><tr><td align="left">tgttggtaagtagatcg</td><td align="left"><italic>PER3</italic></td><td align="left">Period homolog 3 (Drosophila)</td><td align="left">2.07</td><td align="left">1.74</td><td align="left">0.001</td></tr><tr><td align="left">tggctgtatggggaggc</td><td align="left"><italic>SLC25A29</italic></td><td align="left">Solute carrier family 25 member 29</td><td align="left">2.50</td><td align="left">1.22</td><td align="left">0.035</td></tr><tr><td align="left">gatgaagctgggatgca</td><td align="left"><italic>TNNT3</italic></td><td align="left">Troponin T Type 3</td><td align="left">2.93</td><td align="left">0.94</td><td align="left">NS</td></tr></tbody></table><table-wrap-foot><p>The figure for the DGE fold change could not be calculated due to the fact that the PER2 transcript was undetectable pre-training (the transcript had zero counts in all the pre-training samples).</p></table-wrap-foot></table-wrap><p>The <italic>PER2 </italic>and <italic>PER3 </italic>genes, key molecular clock components within the mammalian circadian timing system [<xref ref-type="bibr" rid="B79">79</xref>], had mean post-training increases in expression of +1.88-fold and +1.74 fold respectively. The induction of these genes may represent an entrainment of the muscle transcriptional clock by a regular exercise regime. While primarily regulated by photoperiodic signals to the master pacemaker within the suprachiasmatic nucleus, peripheral circadian clocks, which are known to exist in almost all peripheral tissues examined to date [<xref ref-type="bibr" rid="B80">80</xref>], can also be entrained by alternative timing cues including exercise [<xref ref-type="bibr" rid="B81">81</xref>] and feeding [<xref ref-type="bibr" rid="B82">82</xref>]. The role of peripheral clocks is to align specific tissue function to the correct time of day via differential regulation of subsets of clock-controlled genes.</p><p>As exercise is a known synchroniser of circadian rhythms in mice [<xref ref-type="bibr" rid="B83">83</xref>], humans [<xref ref-type="bibr" rid="B81">81</xref>] and horses [<xref ref-type="bibr" rid="B84">84</xref>], and <italic>PER2 </italic>has previously been shown to oscillate in equine tissues [<xref ref-type="bibr" rid="B85">85</xref>], the increased expression of PER genes post-training in the current study is thought to represent a strengthening of the endogenous circadian clock in equine muscle. Furthermore, human studies have shown time of day variations in exercise performance at the physiological level [<xref ref-type="bibr" rid="B86">86</xref>-<xref ref-type="bibr" rid="B88">88</xref>], and it has been suggested that circadian rhythms may play an important role in sports performance [<xref ref-type="bibr" rid="B89">89</xref>]. Combined with our results, this is strong incentive for further investigation of the influence of training times on daily muscle function in the horse, such that optimal athletic performance may be achieved.</p><p>The proteins encoded by <italic>ACADVL </italic>(+1.72-fold, <italic>P </italic>= 0.014), <italic>MRPS21 </italic>(+6.03-fold, <italic>P </italic>= 0.013) and <italic>SLC25A29 </italic>(+1.22-fold, <italic>P </italic>= 0.350) function in the mitochondria to increase protein synthesis and fat metabolism. The increase in expression of the gene encoding the mitochondrial ribosomal protein MRPS21 likely reflects an increase in mitochondrial protein synthesis and an overall increase in mitochondrial volume. Numerous studies have demonstrated an increase in mitochondrial volume concurrent with an increase in VO<sub>2max </sub>following endurance training [<xref ref-type="bibr" rid="B90">90</xref>-<xref ref-type="bibr" rid="B93">93</xref>]. The proteins encoded by <italic>ACADVL </italic>and <italic>SLC25A29 </italic>are involved in fat metabolism and are located in the mitochondrial inner membrane.</p><p><italic>ACTN3</italic>, <italic>CALM3 </italic>and <italic>DAG1 </italic>were decreased in expression by -1.41-fold (<italic>P </italic>= 0.090), -1.81-fold (P = 0.028) and -1.27-fold (<italic>P </italic>= 0.021) respectively. The ACTN3 protein is localized to the skeletal muscle z-discs and DAG1 forms part of the dystroglycan complex. A null mutation in the <italic>ACTN3 </italic>gene has been associated with sprint performance in human athletes [<xref ref-type="bibr" rid="B94">94</xref>] and <italic>DAG1 </italic>has been proposed as a candidate gene in some muscular myopathies [<xref ref-type="bibr" rid="B95">95</xref>,<xref ref-type="bibr" rid="B96">96</xref>]. CALM3 is an isoform of calmodulin, a calcium-modulated protein which regulate numerous protein targets. The binding of calcium to calmodulin induces a conformational change which affects its ability to bind target proteins. In this manner calmodulin may be used by other proteins as a calcium sensor and signal transducer. CALM3 may be involved in muscle fibre type transformation in response to muscle excitation [<xref ref-type="bibr" rid="B97">97</xref>,<xref ref-type="bibr" rid="B98">98</xref>]. <italic>CALM3 </italic>gene expression was also decreased in equine muscle four hours post exhaustive treadmill exercise [<xref ref-type="bibr" rid="B47">47</xref>].</p><p><italic>IGFBP5 </italic>and <italic>MSTN </italic>encode growth factors with large observed decreases in expression post training (-3.18-fold, <italic>P </italic>= 0.023 and -4.97-fold <italic>P </italic>= 0.004 respectively). IGFBP5 is one of family of modulators of insulin like growth factors (IGFs) which interact with IGFs resulting in an increase in half life and alteration of the interaction with receptors. IGF-1 promotes muscle hypertrophy and protein levels are increased in humans following administration of human growth hormone as an illegal doping agent [<xref ref-type="bibr" rid="B99">99</xref>,<xref ref-type="bibr" rid="B100">100</xref>]. The exact mode of action of IGFBP5 is poorly understood however it has been shown to associate with the extra cellular matrix and is a regulator of a wide range of physiological processes including cell proliferation and muscle cell differentiation [<xref ref-type="bibr" rid="B101">101</xref>-<xref ref-type="bibr" rid="B103">103</xref>].</p><p>Myostatin encoded by the <italic>MSTN </italic>gene is a negative regulator of muscle growth and an inhibitor of satellite cell proliferation[<xref ref-type="bibr" rid="B104">104</xref>]. The expression of <italic>MSTN </italic>was found to be decreased in humans following resistance training [<xref ref-type="bibr" rid="B105">105</xref>,<xref ref-type="bibr" rid="B106">106</xref>]. Null mutations in this gene have been found to cause a double muscling phenotype in cattle, dogs, and humans [<xref ref-type="bibr" rid="B107">107</xref>-<xref ref-type="bibr" rid="B111">111</xref>]. Structural variation in the <italic>MSTN </italic>gene has also been associated with athletic performance in dogs [<xref ref-type="bibr" rid="B110">110</xref>] and horses [<xref ref-type="bibr" rid="B112">112</xref>]. The differential expression of this gene is of particular significance as an intronic SNP in equine <italic>MSTN </italic>has been found to be a strong predictor of optimal racing distance in Thoroughbred racehorses [<xref ref-type="bibr" rid="B112">112</xref>].</p></sec></sec><sec><title>Conclusion</title><p>Deep sequencing of the equine skeletal muscle transcriptome has revealed novel transcripts and functional groups associated with this tissue. Furthermore, following exercise training we have observed an increase in the occurrence of genes involved in metabolism and oxidative phosphorylation, and a decrease in the expression of structural genes. Overrepresented functional groups of genes post-training were associated with both endurance and resistance exercise. This study documents the transcriptome-wide reprogramming of skeletal muscle in Thoroughbred racehorses that brings about the well documented phenotypic adaptations to exercise.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>All animal procedures were approved by the University College Dublin, Animal Research Ethics Committee, a licence was granted from the Department of Health and Children (Ireland) and owners' consent was obtained for all horses.</p><p>Seven two-year-old untrained Thoroughbred horses (<italic>n </italic>= 5 females, <italic>n </italic>= 2 entire males), raised on the same farm for the previous 2 - 3 months and destined for Flat racing with the same trainer comprised the study cohort. The horses had a mean height of 154.9 cm (&#x000b1; 2.8) and a mean pre-training weight of 437.4 kg (&#x000b1; 18.0). All horses undertook a regular exercise regime with the same trainer for 10 months (trained). This consisted of light canter (1,500 m) once a day six times a week on an all-weather gallop and higher intensity exercise ("work") no more than once a week which consisted of warm-up (walk and trot) followed by gallop with velocities reaching maximal intensity for 800-1,000 m.</p></sec><sec><title>Muscle biopsy sampling</title><p>Percutaneous needle muscle biopsies [<xref ref-type="bibr" rid="B113">113</xref>] were obtained from the dorsal compartment of the <italic>gluteus medius </italic>muscle according to Dingboom and colleagues [<xref ref-type="bibr" rid="B114">114</xref>] using a 6 mm diameter, modified Bergstrom biopsy needle (J&#x000f8;rgen KRUUSE, Veterinary Supplies). Biopsies were taken approximately 15 cm caudodorsal (one-third of the distance) to the <italic>tuber coxae </italic>on an imaginary line drawn from the <italic>tuber coxae </italic>to the head of the tail. The biopsies were obtained at a depth of 80 mm. Each biopsy site was shaved, scrubbed with an antiseptic and desensitized by a local anaesthetic. The biopsy samples were washed with sterile PBS (BD Biosciences, San Jose, CA) and preserved in RNA<italic>later </italic>(Ambion, UK) for 24 hours at 4&#x000b0;C and then stored at -20&#x000b0;C. Muscle biopsy samples were collected at rest at two time points: T<sub>0</sub>-untrained and T<sub>2</sub>-trained.</p></sec><sec><title>RNA isolation and purification</title><p>Approximately 100 mg of each muscle biopsy sample was removed from RNA<italic>later </italic>and homogenized in 1 ml TRIzol using a TissueLyser (Qiagen Ltd, Crawley, UK) and extracted according to the manufacturer's instructions. Each sample was purified using the RNeasy<sup>&#x000ae; </sup>Mini kit (Qiagen Ltd, Crawley, UK) and DNase treated with RNase free DNase (Qiagen Ltd, Crawley, UK). RNA was quantified using a NanoDrop<sup>&#x000ae; </sup>ND1000 spectrophotometer V 3.5.2 (NanoDrop Technologies, Wilmington, DE) and RNA quality was subsequently assessed using the 18S/28 S ratio and RNA integrity number (RIN) on an Agilent Bioanalyser with the RNA 6000 Nano LabChip kit (Agilent Technologies Ireland Ltd, Dublin, Ireland) according to the manufacturers' instructions.</p></sec><sec><title>Library preparation for Illumina sequencing</title><p>The Illumina cDNA library was prepared according to the manufacturer's instructions. All reagents were supplied by Illumina apart from SuperScript II Reverse Transcriptase (part # 18064-014) with 100 mM DTT. Briefly, 1.5 &#x003bc;g mRNA was isolated from total RNA by binding the mRNA to a magnetic oligo(dT) bead. Double stranded cDNA was synthesized and cleaved at each <italic>Nla</italic>III site. The site of <italic>Nla</italic>III cleavage was ligated with an Illumina-supplied adaptor using T4 DNA ligase. The bead bound double stranded cDNA was the cut by the restriction enzyme, <italic>Mme</italic>I. This resulted in a 17 bp tag which was no longer attached to the oligo(dT) bead. The cDNA construct was then precipitated and the site of <italic>Mme</italic>I cleavage was ligated with an Illumina-supplied adaptor using T4 DNA ligase. The adaptor ligated cDNA was PCR amplified with two adapter primers (Illumina). The PCR product of 85 bp was purified by gel extraction in preparation for loading on the Illumina Cluster Station. The quality and quantity of the purified constructs were assessed using an Agilent DNA series 7500 series II assay (Agilent Technologies Ireland Ltd, Dublin, Ireland) and Qubit fluorometer according to manufacturer's instructions. Cluster generation and sequencing analysis were carried out using Illumina's Solexa Sequencer according to the manufacturer's instructions.</p></sec><sec><title>Analysis</title><p>The DGE samples were processed through the standard software pipeline provided by Illumina for the Genome Analyzer. The sequence reads were base called using the Bustard base caller (part of the Illumina software). The tag annotation pipeline consisted of two parts: mapping to known Ensembl [<xref ref-type="bibr" rid="B115">115</xref>] cDNAs and mapping to the genome. The known cDNAs from version 49 of Ensembl for the EquCab2 assembly of the equine genome were downloaded in FASTA format using the Ensembl biomart tool. The FASTA files for the individual equine chromosomes were downloaded from the UCSC genome browser website [<xref ref-type="bibr" rid="B116">116</xref>]. A pipeline consisting of perl, C++ and linux shell scripts was used to conduct an <italic>in-silico </italic>digestion of both the transcriptome and genome and to generate tag location records which were loaded into a MySQL database. The tag records were then annotated according to their type (genomic or cDNA, canonical, noncanonical, repeat etc.). A matrix of tag counts for each sample was generated. The edgeR Bioconductor package [<xref ref-type="bibr" rid="B117">117</xref>] was used to determine differential expression of tags in each group.</p></sec><sec><title>Functional clustering according to gene ontology annotations</title><p>The equine Ensembl gene IDs were cross-matched to human Ensembl gene IDs. Using the Ensembl IDs of human homologues of equine genes it was possible to use the Database for Annotation, Visualization and Integrated Discovery (DAVID) [<xref ref-type="bibr" rid="B118">118</xref>,<xref ref-type="bibr" rid="B119">119</xref>] for functional clustering and overrepresentation analyses. The Expression Analysis Systematic Explorer (EASE) tool [<xref ref-type="bibr" rid="B120">120</xref>] within DAVID was used to investigate the representation of functional groups in equine skeletal muscle relative to the whole genome. The FatiScan [<xref ref-type="bibr" rid="B121">121</xref>,<xref ref-type="bibr" rid="B122">122</xref>] gene enrichment test was used to analyse the transcriptional profile post-training. FatiScan is part of the Babelomics Suite of web tools and tests for the asymmetrical distribution of biological labels in an ordered list of genes through application of a Fisher's exact test. Genes were ranked by differential expression and FatiScan was used to detect functional blocks (GO and KEGG pathways) that were significantly up-regulated and down-regulated post-training. Results from both EASE and FatiScan were corrected for multiple testing using the Benjamini and Hochberg method [<xref ref-type="bibr" rid="B123">123</xref>].</p></sec><sec><title>Real time quantitative RT-PCR</title><p>Selected cDNA samples were quantified by real time quantitative RT-PCR (qRT-PCR). 1 &#x003bc;g of total RNA from each sample was reverse transcribed into cDNA with oligo-dT primers using a SuperScript&#x02122; III first strand synthesis SuperMix kit according to the manufacturer's instructions (Invitrogen Ltd, Paisley, UK). The converted cDNA was diluted to 2.5 ng/&#x003bc;l working stocks and stored at -20&#x000b0;C for subsequent analyses. Oligonucleotide primers for real time qRT-PCR were designed using Primer3 version 3.0 <ext-link ext-link-type="uri" xlink:href="http://www.primer3.sourceforge.net">http://www.primer3.sourceforge.net</ext-link> and commercially synthesized (MWG Biotech, Germany). Primer details are shown in Table <xref ref-type="table" rid="T8">8</xref>. Each reaction was carried out in a total volume of 20 &#x003bc;l with 5 &#x003bc;l of cDNA (1 ng/&#x003bc;l), 10 &#x003bc;l SYBR<sup>&#x000ae; </sup>Green PCR Master Mix (Applied Biosystems, Cambridgeshire, UK) and 5 &#x003bc;l primer/H<sub>2</sub>O. Real time qRT-PCR was performed using a 7500 Fast Real-Time PCR machine (Applied Biosystems, Cambridgeshire, UK). All reactions were performed in duplicate. Hypoxanthine phosphoribosyltransferase 1 (<italic>HPRT</italic>) was selected as a stable reference gene based on a study of equine reference genes for real time qRT-PCR [<xref ref-type="bibr" rid="B124">124</xref>] and on the DGE results. Expression values were calculated using a standard curve which was plotted based on the expression of <italic>HPRT </italic>in serial dilutions of equine skeletal muscle RNA (1:1, 1:2, 1:4, 1:8, 1:16, 1:32, and 1:64). The standard curve method was used to normalise the gene expression data. The paired Student's t-test was used to identify significant differences in mRNA abundance between time-points.</p><table-wrap id="T8" position="float"><label>Table 8</label><caption><p>Real time qRT-PCR primers for genes used to validate DGE data</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Gene symbol</th><th align="left">Forward Primer</th><th align="left">Reverse Primer</th></tr></thead><tbody><tr><td align="left"><italic>ACADVL</italic></td><td align="left">ctgcccagcgatcctatg</td><td align="left">ttccactggtcgaagtctca</td></tr><tr><td align="left"><italic>ACTN3</italic></td><td align="left">cggcgagtatatggaacagg</td><td align="left">gtgagttgcaccaggcagt</td></tr><tr><td align="left"><italic>CALM</italic></td><td align="left">agcacttggtggactccttg</td><td align="left">aaatgcctgactgtgctcaa</td></tr><tr><td align="left"><italic>DAG1</italic></td><td align="left">ccaggaggagtgagcacct</td><td align="left">ctcaccctctgcacacctg</td></tr><tr><td align="left"><italic>IGFBP5</italic></td><td align="left">ggaggagccgagaacactg</td><td align="left">gcgaagcctccatgtgtc</td></tr><tr><td align="left"><italic>MRPS21</italic></td><td align="left">ggagatctgctgtttgctca</td><td align="left">tctctcaaagcgacccatct</td></tr><tr><td align="left"><italic>MSTN</italic></td><td align="left">tgacagcagtgatggctctt</td><td align="left">ttgggttttccttccacttg</td></tr><tr><td align="left"><italic>PER2</italic></td><td align="left">agcctgatgatggcgaagtctgaa</td><td align="left">agttctttgtgcgtgtctgccttg</td></tr><tr><td align="left"><italic>PER3</italic></td><td align="left">aactatgcccttcgctgtgt</td><td align="left">gtacccggtcacatctgctt</td></tr><tr><td align="left"><italic>SLC25A29</italic></td><td align="left">ggacacccgtttgacactg</td><td align="left">ctgatgatggattggaagca</td></tr><tr><td align="left"><italic>TNNT3</italic></td><td align="left">cggagggggagaaagtagac</td><td align="left">caaagtggctgtcgatgaga</td></tr></tbody></table></table-wrap></sec></sec><sec><title>Authors' contributions</title><p>BMcG &#x00026; EH designed the experiment. BMcG, EH, LK and RF participated in the collection of samples. BMcG performed the RNA extractions. BMcG and JB generated the cDNA libraries. BMcG performed the real time qRT-PCR experiments. PM was responsible for the bioinformatics pipeline. AL, BL and AE were responsible for the sequencing project. BMcG performed functional analysis of the data. PM, BM and DMacH assisted with manuscript preparation. BMcG and EH wrote the paper. EH coordinated and supervised the project. All authors read and approved the final manuscript.</p></sec></body><back><sec><title>Acknowledgements</title><p>The authors thank JS Bolger for access to horses. We thank P O'Donovan and Glebe House yard staff for assistance with sample collection. This work was financed by a Science Foundation Ireland President of Ireland Young Researcher Award (04/YI1/B539) to EH. AE and PM were funded by Science Foundation Ireland (07/SRC/B1156).</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Saltin</surname><given-names>B</given-names></name><name><surname>Hartley</surname><given-names>LH</given-names></name><name><surname>Kilbom</surname><given-names>A</given-names></name><name><surname>Astrand</surname><given-names>I</given-names></name><article-title>Physical training in sedentary middle-aged and older men. II. Oxygen uptake, heart rate, and blood lactate concentration at submaximal and maximal exercise</article-title><source>Scand J Clin Lab Invest</source><year>1969</year><volume>24</volume><issue>4</issue><fpage>323</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.3109/00365516909080169</pub-id><pub-id pub-id-type="pmid">5383327</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Adhihetty</surname><given-names>PJ</given-names></name><name><surname>Irrcher</surname><given-names>I</given-names></name><name><surname>Joseph</surname><given-names>AM</given-names></name><name><surname>Ljubicic</surname><given-names>V</given-names></name><name><surname>Hood</surname><given-names>DA</given-names></name><article-title>Plasticity of skeletal muscle mitochondria in response to contractile activity</article-title><source>Exp Physiol</source><year>2003</year><volume>88</volume><issue>1</issue><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1113/eph8802505</pub-id><pub-id pub-id-type="pmid">12525859</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Holloszy</surname><given-names>JO</given-names></name><name><surname>Rennie</surname><given-names>MJ</given-names></name><name><surname>Hickson</surname><given-names>RC</given-names></name><name><surname>Conlee</surname><given-names>RK</given-names></name><name><surname>Hagberg</surname><given-names>JM</given-names></name><article-title>Physiological consequences of the biochemical adaptations to endurance exercise</article-title><source>Ann N Y Acad Sci</source><year>1977</year><volume>301</volume><fpage>440</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.1977.tb38220.x</pub-id><pub-id pub-id-type="pmid">337873</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Hartman</surname><given-names>JW</given-names></name><name><surname>Moore</surname><given-names>DR</given-names></name><name><surname>Phillips</surname><given-names>SM</given-names></name><article-title>Resistance training reduces whole-body protein turnover and improves net protein retention in untrained young males</article-title><source>Appl Physiol Nutr Metab</source><year>2006</year><volume>31</volume><issue>5</issue><fpage>557</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1139/H06-031</pub-id><pub-id pub-id-type="pmid">17111010</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Yarasheski</surname><given-names>KE</given-names></name><name><surname>Zachwieja</surname><given-names>JJ</given-names></name><name><surname>Bier</surname><given-names>DM</given-names></name><article-title>Acute effects of resistance exercise on muscle protein synthesis rate in young and elderly men and women</article-title><source>Am J Physiol</source><year>1993</year><volume>265</volume><issue>2 Pt 1</issue><fpage>E210</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">8368290</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Nader</surname><given-names>GA</given-names></name><name><surname>Esser</surname><given-names>KA</given-names></name><article-title>Intracellular signaling specificity in skeletal muscle in response to different modes of exercise</article-title><source>J Appl Physiol</source><year>2001</year><volume>90</volume><issue>5</issue><fpage>1936</fpage><lpage>1942</lpage><pub-id pub-id-type="pmid">11299288</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Roneus</surname><given-names>M</given-names></name><name><surname>Essen-Gustavsson</surname><given-names>B</given-names></name><name><surname>Lindholm</surname><given-names>A</given-names></name><name><surname>Persson</surname><given-names>SG</given-names></name><article-title>Skeletal muscle characteristics in young trained and untrained standardbred trotters</article-title><source>Equine Vet J</source><year>1992</year><volume>24</volume><issue>4</issue><fpage>292</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1111/j.2042-3306.1992.tb02838.x</pub-id><pub-id pub-id-type="pmid">1499537</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Roneus</surname><given-names>M</given-names></name><article-title>Muscle characteristics in standardbreds of different ages and sexes</article-title><source>Equine Vet J</source><year>1993</year><volume>25</volume><issue>2</issue><fpage>143</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1111/j.2042-3306.1993.tb02925.x</pub-id><pub-id pub-id-type="pmid">8467774</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Katz</surname><given-names>LM</given-names></name><name><surname>Bayly</surname><given-names>WM</given-names></name><name><surname>Hines</surname><given-names>MT</given-names></name><name><surname>Sides</surname><given-names>RH</given-names></name><article-title>Differences in the ventilatory responses of horses and ponies to exercise of varying intensities</article-title><source>Equine Vet J Suppl</source><year>1999</year><volume>30</volume><fpage>49</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">10659221</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Serrano</surname><given-names>AL</given-names></name><name><surname>Quiroz-Rothe</surname><given-names>E</given-names></name><name><surname>Rivero</surname><given-names>JL</given-names></name><article-title>Early and long-term changes of equine skeletal muscle in response to endurance training and detraining</article-title><source>Pflugers Arch</source><year>2000</year><volume>441</volume><issue>2-3</issue><fpage>263</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1007/s004240000408</pub-id><pub-id pub-id-type="pmid">11211112</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Hinchcliff</surname><given-names>KW</given-names></name><name><surname>Lauderdale</surname><given-names>MA</given-names></name><name><surname>Dutson</surname><given-names>J</given-names></name><name><surname>Geor</surname><given-names>RJ</given-names></name><name><surname>Lacombe</surname><given-names>VA</given-names></name><name><surname>Taylor</surname><given-names>LE</given-names></name><article-title>High intensity exercise conditioning increases accumulated oxygen deficit of horses</article-title><source>Equine Vet J</source><year>2002</year><volume>34</volume><issue>1</issue><fpage>9</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.2746/042516402776181150</pub-id><pub-id pub-id-type="pmid">11817558</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="other"><name><surname>McGowan</surname><given-names>CM</given-names></name><name><surname>Golland</surname><given-names>LC</given-names></name><name><surname>Evans</surname><given-names>DL</given-names></name><name><surname>Hodgson</surname><given-names>DR</given-names></name><name><surname>Rose</surname><given-names>RJ</given-names></name><article-title>Effects of prolonged training, overtraining and detraining on skeletal muscle metabolites and enzymes</article-title><source>Equine Vet J Suppl</source><year>2002</year><issue>34</issue><fpage>257</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">12405697</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="other"><name><surname>Rivero</surname><given-names>JL</given-names></name><name><surname>Ruz</surname><given-names>A</given-names></name><name><surname>Marti-Korfft</surname><given-names>S</given-names></name><name><surname>Lindner</surname><given-names>A</given-names></name><article-title>Contribution of exercise intensity and duration to training-linked myosin transitions in thoroughbreds</article-title><source>Equine Vet J Suppl</source><year>2006</year><issue>36</issue><fpage>311</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">17402438</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Yamano</surname><given-names>S</given-names></name><name><surname>Eto</surname><given-names>D</given-names></name><name><surname>Sugiura</surname><given-names>T</given-names></name><name><surname>Kai</surname><given-names>M</given-names></name><name><surname>Hiraga</surname><given-names>A</given-names></name><name><surname>Tokuriki</surname><given-names>M</given-names></name><name><surname>Miyata</surname><given-names>H</given-names></name><article-title>Effect of growth and training on muscle adaptation in Thoroughbred horses</article-title><source>Am J Vet Res</source><year>2002</year><volume>63</volume><issue>10</issue><fpage>1408</fpage><lpage>1412</lpage><pub-id pub-id-type="doi">10.2460/ajvr.2002.63.1408</pub-id><pub-id pub-id-type="pmid">12371768</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Eto</surname><given-names>D</given-names></name><name><surname>Yamano</surname><given-names>S</given-names></name><name><surname>Mukai</surname><given-names>K</given-names></name><name><surname>Sugiura</surname><given-names>T</given-names></name><name><surname>Nasu</surname><given-names>T</given-names></name><name><surname>Tokuriki</surname><given-names>M</given-names></name><name><surname>Miyata</surname><given-names>H</given-names></name><article-title>Effect of high intensity training on anaerobic capacity of middle gluteal muscle in Thoroughbred horses</article-title><source>Res Vet Sci</source><year>2004</year><volume>76</volume><issue>2</issue><fpage>139</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.rvsc.2003.08.010</pub-id><pub-id pub-id-type="pmid">14672857</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="other"><name><surname>Rivero</surname><given-names>JL</given-names></name><name><surname>Sporleder</surname><given-names>HP</given-names></name><name><surname>Quiroz-Rothe</surname><given-names>E</given-names></name><name><surname>Vervuert</surname><given-names>I</given-names></name><name><surname>Coenen</surname><given-names>M</given-names></name><name><surname>Harmeyer</surname><given-names>J</given-names></name><article-title>Oral L-carnitine combined with training promotes changes in skeletal muscle</article-title><source>Equine Vet J Suppl</source><volume>2002</volume><issue>34</issue><fpage>269</fpage><lpage>274</lpage></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Bickel</surname><given-names>CS</given-names></name><name><surname>Slade</surname><given-names>J</given-names></name><name><surname>Mahoney</surname><given-names>E</given-names></name><name><surname>Haddad</surname><given-names>F</given-names></name><name><surname>Dudley</surname><given-names>GA</given-names></name><name><surname>Adams</surname><given-names>GR</given-names></name><article-title>Time course of molecular responses of human skeletal muscle to acute bouts of resistance exercise</article-title><source>J Appl Physiol</source><year>2005</year><volume>98</volume><issue>2</issue><fpage>482</fpage><lpage>488</lpage><pub-id pub-id-type="pmid">15465884</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Neufer</surname><given-names>PD</given-names></name><name><surname>Dohm</surname><given-names>GL</given-names></name><article-title>Exercise induces a transient increase in transcription of the GLUT-4 gene in skeletal muscle</article-title><source>Am J Physiol</source><year>1993</year><volume>265</volume><issue>6 Pt 1</issue><fpage>C1597</fpage><lpage>1603</lpage><pub-id pub-id-type="pmid">7506491</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Creer</surname><given-names>A</given-names></name><name><surname>Jemiolo</surname><given-names>B</given-names></name><name><surname>Trappe</surname><given-names>S</given-names></name><article-title>Time course of myogenic and metabolic gene expression in response to acute exercise in human skeletal muscle</article-title><source>J Appl Physiol</source><year>2005</year><volume>98</volume><issue>5</issue><fpage>1745</fpage><lpage>1752</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01185.2004</pub-id><pub-id pub-id-type="pmid">15618316</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Pilegaard</surname><given-names>H</given-names></name><name><surname>Saltin</surname><given-names>B</given-names></name><name><surname>Neufer</surname><given-names>PD</given-names></name><article-title>Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle</article-title><source>J Physiol</source><year>2003</year><volume>546</volume><issue>Pt 3</issue><fpage>851</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2002.034850</pub-id><pub-id pub-id-type="pmid">12563009</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Mahoney</surname><given-names>DJ</given-names></name><name><surname>Parise</surname><given-names>G</given-names></name><name><surname>Melov</surname><given-names>S</given-names></name><name><surname>Safdar</surname><given-names>A</given-names></name><name><surname>Tarnopolsky</surname><given-names>MA</given-names></name><article-title>Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise</article-title><source>FASEB J</source><year>2005</year><volume>19</volume><issue>11</issue><fpage>1498</fpage><lpage>1500</lpage><pub-id pub-id-type="pmid">15985525</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Schmutz</surname><given-names>S</given-names></name><name><surname>Dapp</surname><given-names>C</given-names></name><name><surname>Wittwer</surname><given-names>M</given-names></name><name><surname>Vogt</surname><given-names>M</given-names></name><name><surname>Hoppeler</surname><given-names>H</given-names></name><name><surname>Fluck</surname><given-names>M</given-names></name><article-title>Endurance training modulates the muscular transcriptome response to acute exercise</article-title><source>Pflugers Arch</source><year>2006</year><volume>451</volume><issue>5</issue><fpage>678</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1007/s00424-005-1497-0</pub-id><pub-id pub-id-type="pmid">16362354</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Klossner</surname><given-names>S</given-names></name><name><surname>Dapp</surname><given-names>C</given-names></name><name><surname>Schmutz</surname><given-names>S</given-names></name><name><surname>Vogt</surname><given-names>M</given-names></name><name><surname>Hoppeler</surname><given-names>H</given-names></name><name><surname>Fluck</surname><given-names>M</given-names></name><article-title>Muscle transcriptome adaptations with mild eccentric ergometer exercise</article-title><source>Pflugers Arch</source><year>2007</year><volume>455</volume><issue>3</issue><fpage>555</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1007/s00424-007-0303-6</pub-id><pub-id pub-id-type="pmid">17701424</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Puntschart</surname><given-names>A</given-names></name><name><surname>Claassen</surname><given-names>H</given-names></name><name><surname>Jostarndt</surname><given-names>K</given-names></name><name><surname>Hoppeler</surname><given-names>H</given-names></name><name><surname>Billeter</surname><given-names>R</given-names></name><article-title>mRNAs of enzymes involved in energy metabolism and mtDNA are increased in endurance-trained athletes</article-title><source>Am J Physiol</source><year>1995</year><volume>269</volume><issue>3 Pt 1</issue><fpage>C619</fpage><lpage>625</lpage><pub-id pub-id-type="pmid">7573391</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Stepto</surname><given-names>NK</given-names></name><name><surname>Coffey</surname><given-names>VG</given-names></name><name><surname>Carey</surname><given-names>AL</given-names></name><name><surname>Ponnampalam</surname><given-names>AP</given-names></name><name><surname>Canny</surname><given-names>BJ</given-names></name><name><surname>Powell</surname><given-names>D</given-names></name><name><surname>Hawley</surname><given-names>JA</given-names></name><article-title>Global gene expression in skeletal muscle from well-trained strength and endurance athletes</article-title><source>Med Sci Sports Exerc</source><year>2009</year><volume>41</volume><issue>3</issue><fpage>546</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e31818c6be9</pub-id><pub-id pub-id-type="pmid">19204596</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Atherton</surname><given-names>PJ</given-names></name><name><surname>Babraj</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>K</given-names></name><name><surname>Singh</surname><given-names>J</given-names></name><name><surname>Rennie</surname><given-names>MJ</given-names></name><name><surname>Wackerhage</surname><given-names>H</given-names></name><article-title>Selective activation of AMPK-PGC-1alpha or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation</article-title><source>FASEB J</source><year>2005</year><volume>19</volume><issue>7</issue><fpage>786</fpage><lpage>788</lpage><pub-id pub-id-type="pmid">15716393</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Coffey</surname><given-names>VG</given-names></name><name><surname>Zhong</surname><given-names>Z</given-names></name><name><surname>Shield</surname><given-names>A</given-names></name><name><surname>Canny</surname><given-names>BJ</given-names></name><name><surname>Chibalin</surname><given-names>AV</given-names></name><name><surname>Zierath</surname><given-names>JR</given-names></name><name><surname>Hawley</surname><given-names>JA</given-names></name><article-title>Early signaling responses to divergent exercise stimuli in skeletal muscle from well-trained humans</article-title><source>FASEB J</source><year>2006</year><volume>20</volume><issue>1</issue><fpage>190</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">16267123</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Coffey</surname><given-names>VG</given-names></name><name><surname>Pilegaard</surname><given-names>H</given-names></name><name><surname>Garnham</surname><given-names>AP</given-names></name><name><surname>O'Brien</surname><given-names>BJ</given-names></name><name><surname>Hawley</surname><given-names>JA</given-names></name><article-title>Consecutive bouts of diverse contractile activity alter acute responses in human skeletal muscle</article-title><source>J Appl Physiol</source><year>2009</year><volume>106</volume><issue>4</issue><fpage>1187</fpage><lpage>1197</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.91221.2008</pub-id><pub-id pub-id-type="pmid">19164772</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Coffey</surname><given-names>VG</given-names></name><name><surname>Reeder</surname><given-names>DW</given-names></name><name><surname>Lancaster</surname><given-names>GI</given-names></name><name><surname>Yeo</surname><given-names>WK</given-names></name><name><surname>Febbraio</surname><given-names>MA</given-names></name><name><surname>Yaspelkis</surname><given-names>BB</given-names></name><name><surname>Hawley</surname><given-names>JA</given-names></name><article-title>Effect of high-frequency resistance exercise on adaptive responses in skeletal muscle</article-title><source>Med Sci Sports Exerc</source><year>2007</year><volume>39</volume><issue>12</issue><fpage>2135</fpage><lpage>2144</lpage><pub-id pub-id-type="doi">10.1249/mss.0b013e31815729b6</pub-id><pub-id pub-id-type="pmid">18046184</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Nader</surname><given-names>GA</given-names></name><article-title>Concurrent strength and endurance training: from molecules to man</article-title><source>Med Sci Sports Exerc</source><year>2006</year><volume>38</volume><issue>11</issue><fpage>1965</fpage><lpage>1970</lpage><pub-id pub-id-type="doi">10.1249/01.mss.0000233795.39282.33</pub-id><pub-id pub-id-type="pmid">17095931</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Hickson</surname><given-names>RC</given-names></name><article-title>Interference of strength development by simultaneously training for strength and endurance</article-title><source>Eur J Appl Physiol Occup Physiol</source><year>1980</year><volume>45</volume><issue>2-3</issue><fpage>255</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1007/BF00421333</pub-id><pub-id pub-id-type="pmid">7193134</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Sale</surname><given-names>DG</given-names></name><name><surname>Jacobs</surname><given-names>I</given-names></name><name><surname>MacDougall</surname><given-names>JD</given-names></name><name><surname>Garner</surname><given-names>S</given-names></name><article-title>Comparison of two regimens of concurrent strength and endurance training</article-title><source>Med Sci Sports Exerc</source><year>1990</year><volume>22</volume><issue>3</issue><fpage>348</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">2381303</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>McCarthy</surname><given-names>JP</given-names></name><name><surname>Agre</surname><given-names>JC</given-names></name><name><surname>Graf</surname><given-names>BK</given-names></name><name><surname>Pozniak</surname><given-names>MA</given-names></name><name><surname>Vailas</surname><given-names>AC</given-names></name><article-title>Compatibility of adaptive responses with combining strength and endurance training</article-title><source>Med Sci Sports Exerc</source><year>1995</year><volume>27</volume><issue>3</issue><fpage>429</fpage><lpage>436</lpage><pub-id pub-id-type="pmid">7752872</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Shaw</surname><given-names>BS</given-names></name><name><surname>Shaw</surname><given-names>I</given-names></name><article-title>Compatibility of concurrent aerobic and resistance training on maximal aerobic capacity in sedentary males</article-title><source>Cardiovasc J Afr</source><year>2009</year><volume>20</volume><issue>2</issue><fpage>104</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">19421643</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>WJ</given-names></name><name><surname>Wood</surname><given-names>DT</given-names></name><name><surname>Andrews</surname><given-names>RG</given-names></name><name><surname>Elkind</surname><given-names>LM</given-names></name><name><surname>Davis</surname><given-names>WB</given-names></name><article-title>Concurrent training enhances athletes' strength, muscle endurance, and other measures</article-title><source>J Strength Cond Res</source><year>2008</year><volume>22</volume><issue>5</issue><fpage>1487</fpage><lpage>1502</lpage><pub-id pub-id-type="pmid">18714239</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Poole</surname><given-names>D</given-names></name><article-title>Current concepts of oxygen transport during exercise</article-title><source>Equine and Comparative Exercise Physiology</source><year>2003</year><volume>1</volume><fpage>5</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1079/ECP20036</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="other"><name><surname>Young</surname><given-names>LE</given-names></name><name><surname>Marlin</surname><given-names>DJ</given-names></name><name><surname>Deaton</surname><given-names>C</given-names></name><name><surname>Brown-Feltner</surname><given-names>H</given-names></name><name><surname>Roberts</surname><given-names>CA</given-names></name><name><surname>Wood</surname><given-names>JL</given-names></name><article-title>Heart size estimated by echocardiography correlates with maximal oxygen uptake</article-title><source>Equine Vet J Suppl</source><year>2002</year><issue>34</issue><fpage>467</fpage><lpage>471</lpage><pub-id pub-id-type="pmid">12405735</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Jones</surname><given-names>JH</given-names></name><name><surname>Longworth</surname><given-names>KE</given-names></name><name><surname>Lindholm</surname><given-names>A</given-names></name><name><surname>Conley</surname><given-names>KE</given-names></name><name><surname>Karas</surname><given-names>RH</given-names></name><name><surname>Kayar</surname><given-names>SR</given-names></name><name><surname>Taylor</surname><given-names>CR</given-names></name><article-title>Oxygen transport during exercise in large mammals. I. Adaptive variation in oxygen demand</article-title><source>J Appl Physiol</source><year>1989</year><volume>67</volume><issue>2</issue><fpage>862</fpage><lpage>870</lpage><pub-id pub-id-type="pmid">2793686</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Banister</surname><given-names>EW</given-names></name><name><surname>Purvis</surname><given-names>AD</given-names></name><article-title>Exercise electrocardiography in the horse by radiotelemetry</article-title><source>J Am Vet Med Assoc</source><year>1968</year><volume>152</volume><issue>7</issue><fpage>1004</fpage><lpage>1008</lpage><pub-id pub-id-type="pmid">5689155</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><name><surname>Marsland</surname><given-names>WP</given-names></name><article-title>Heart rate response to submaximal exercise in the Standardbred horse</article-title><source>J Appl Physiol</source><year>1968</year><volume>24</volume><issue>1</issue><fpage>98</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">5635777</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><name><surname>Asheim</surname><given-names>A</given-names></name><name><surname>Knudsen</surname><given-names>O</given-names></name><name><surname>Lindholm</surname><given-names>A</given-names></name><name><surname>Rulcker</surname><given-names>C</given-names></name><name><surname>Saltin</surname><given-names>B</given-names></name><article-title>Heart rates and blood lactate concentrations of standardbred horses during training and racing</article-title><source>J Am Vet Med Assoc</source><year>1970</year><volume>157</volume><issue>3</issue><fpage>304</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">5448842</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><name><surname>Hall</surname><given-names>MC</given-names></name><name><surname>Steel</surname><given-names>JD</given-names></name><name><surname>Stewart</surname><given-names>GA</given-names></name><article-title>Cardiac monitoring during exercise tests in the horse. 2. Heart rate responses to exercise</article-title><source>Australian veterinary journal</source><year>1976</year><volume>52</volume><issue>1</issue><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1111/j.1751-0813.1976.tb05358.x</pub-id><pub-id pub-id-type="pmid">1267730</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><name><surname>Kayar</surname><given-names>SR</given-names></name><name><surname>Hoppeler</surname><given-names>H</given-names></name><name><surname>Lindstedt</surname><given-names>SL</given-names></name><name><surname>Claassen</surname><given-names>H</given-names></name><name><surname>Jones</surname><given-names>JH</given-names></name><name><surname>Essen-Gustavsson</surname><given-names>B</given-names></name><name><surname>Taylor</surname><given-names>CR</given-names></name><article-title>Total muscle mitochondrial volume in relation to aerobic capacity of horses and steers</article-title><source>Pflugers Arch</source><year>1989</year><volume>413</volume><issue>4</issue><fpage>343</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1007/BF00584481</pub-id><pub-id pub-id-type="pmid">2928085</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><name><surname>Hargreaves</surname><given-names>BJ</given-names></name><name><surname>Kronfeld</surname><given-names>DS</given-names></name><name><surname>Naylor</surname><given-names>JR</given-names></name><article-title>Ambient temperature and relative humidity influenced packed cell volume, total plasma protein and other variables in horses during an incremental submaximal field exercise test</article-title><source>Equine Vet J</source><year>1999</year><volume>31</volume><issue>4</issue><fpage>314</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1111/j.2042-3306.1999.tb03823.x</pub-id><pub-id pub-id-type="pmid">10454090</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><name><surname>Guthrie</surname><given-names>AJ</given-names></name><name><surname>Lund</surname><given-names>RJ</given-names></name><article-title>Thermoregulation</article-title><source>Vet Clin North Am, Equine Pract</source><year>1998</year><volume>14</volume><fpage>45</fpage><lpage>59</lpage></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="other"><name><surname>Gunn</surname><given-names>HM</given-names></name><article-title>Muscle, bone and fat proportions and muscle distribution of Thoroughbreds and other horses</article-title><source>JR Gillespie and NE Robinson, Editors, Equine exercise physiology 2 Davis, ICEEP, CA</source><year>1987</year><fpage>253</fpage><lpage>264</lpage></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><name><surname>McGivney</surname><given-names>BA</given-names></name><name><surname>Eivers</surname><given-names>SS</given-names></name><name><surname>MacHugh</surname><given-names>DE</given-names></name><name><surname>MacLeod</surname><given-names>JN</given-names></name><name><surname>O'Gorman</surname><given-names>GM</given-names></name><name><surname>Park</surname><given-names>SD</given-names></name><name><surname>Katz</surname><given-names>LM</given-names></name><name><surname>Hill</surname><given-names>EW</given-names></name><article-title>Transcriptional adaptations following exercise in thoroughbred horse skeletal muscle highlights molecular mechanisms that lead to muscle hypertrophy</article-title><source>BMC Genomics</source><year>2009</year><volume>10</volume><fpage>638</fpage><pub-id pub-id-type="doi">10.1186/1471-2164-10-638</pub-id><pub-id pub-id-type="pmid">20042072</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><name><surname>Mienaltowski</surname><given-names>MJ</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Frisbie</surname><given-names>DD</given-names></name><name><surname>McIlwraith</surname><given-names>CW</given-names></name><name><surname>Stromberg</surname><given-names>AJ</given-names></name><name><surname>Bathke</surname><given-names>AC</given-names></name><name><surname>Macleod</surname><given-names>JN</given-names></name><article-title>Transcriptional profiling differences for articular cartilage and repair tissue in equine joint surface lesions</article-title><source>BMC Med Genomics</source><year>2009</year><volume>2</volume><fpage>60</fpage><pub-id pub-id-type="doi">10.1186/1755-8794-2-60</pub-id><pub-id pub-id-type="pmid">19751507</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><name><surname>Bright</surname><given-names>LA</given-names></name><name><surname>Burgess</surname><given-names>SC</given-names></name><name><surname>Chowdhary</surname><given-names>B</given-names></name><name><surname>Swiderski</surname><given-names>CE</given-names></name><name><surname>McCarthy</surname><given-names>FM</given-names></name><article-title>Structural and functional-annotation of an equine whole genome oligoarray</article-title><source>BMC Bioinformatics</source><year>2009</year><volume>10</volume><issue>Suppl 11</issue><fpage>S8</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-10-S11-S8</pub-id><pub-id pub-id-type="pmid">19811692</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="other"><name><surname>Morrissy</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Delaney</surname><given-names>A</given-names></name><name><surname>Asano</surname><given-names>J</given-names></name><name><surname>Dhalla</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>I</given-names></name><name><surname>McDonald</surname><given-names>H</given-names></name><name><surname>Pandoh</surname><given-names>P</given-names></name><name><surname>Prabhu</surname><given-names>AL</given-names></name><name><surname>Tam</surname><given-names>A</given-names></name><etal/><article-title>Digital gene expression by tag sequencing on the illumina genome analyzer</article-title><source>Curr Protoc Hum Genet</source><volume>Chapter 11</volume><issue>Unit 11 11</issue><fpage>11</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">20373513</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="other"><name><surname>Serteyn</surname><given-names>D</given-names></name><name><surname>Piquemal</surname><given-names>D</given-names></name><name><surname>Vanderheyden</surname><given-names>L</given-names></name><name><surname>Lejeune</surname><given-names>JP</given-names></name><name><surname>Verwilghen</surname><given-names>D</given-names></name><name><surname>Sandersen</surname><given-names>C</given-names></name><article-title>Gene expression profiling from leukocytes of horses affected by osteochondrosis</article-title><source>J Orthop Res</source><volume>28</volume><issue>7</issue><fpage>965</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">20108324</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><name><surname>Asmann</surname><given-names>YW</given-names></name><name><surname>Klee</surname><given-names>EW</given-names></name><name><surname>Thompson</surname><given-names>EA</given-names></name><name><surname>Perez</surname><given-names>EA</given-names></name><name><surname>Middha</surname><given-names>S</given-names></name><name><surname>Oberg</surname><given-names>AL</given-names></name><name><surname>Therneau</surname><given-names>TM</given-names></name><name><surname>Smith</surname><given-names>DI</given-names></name><name><surname>Poland</surname><given-names>GA</given-names></name><name><surname>Wieben</surname><given-names>ED</given-names></name><etal/><article-title>3' tag digital gene expression profiling of human brain and universal reference RNA using Illumina Genome Analyzer</article-title><source>BMC Genomics</source><year>2009</year><volume>10</volume><fpage>531</fpage><pub-id pub-id-type="doi">10.1186/1471-2164-10-531</pub-id><pub-id pub-id-type="pmid">19917133</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><name><surname>Velculescu</surname><given-names>VE</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name><article-title>Serial analysis of gene expression</article-title><source>Science</source><year>1995</year><volume>270</volume><issue>5235</issue><fpage>484</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.1126/science.270.5235.484</pub-id><pub-id pub-id-type="pmid">7570003</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="other"><name><surname>Coleman</surname><given-names>SJ</given-names></name><name><surname>Zeng</surname><given-names>Z</given-names></name><name><surname>Mienaltowske</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>MacLeod</surname><given-names>JN</given-names></name><article-title>Analysis Of Equine Structural Gene Annotation By RNA Sequencing</article-title><source>Plant &#x00026; Animal Genomes XVII Conference: 2009; San Diego, CA</source><year>2009</year></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><name><surname>Oshlack</surname><given-names>A</given-names></name><name><surname>Wakefield</surname><given-names>MJ</given-names></name><article-title>Transcript length bias in RNA-seq data confounds systems biology</article-title><source>Biol Direct</source><year>2009</year><volume>4</volume><fpage>14</fpage><pub-id pub-id-type="doi">10.1186/1745-6150-4-14</pub-id><pub-id pub-id-type="pmid">19371405</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><name><surname>Welle</surname><given-names>S</given-names></name><name><surname>Bhatt</surname><given-names>K</given-names></name><name><surname>Thornton</surname><given-names>CA</given-names></name><article-title>Inventory of high-abundance mRNAs in skeletal muscle of normal men</article-title><source>Genome Res</source><year>1999</year><volume>9</volume><issue>5</issue><fpage>506</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">10330131</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><name><surname>Payne</surname><given-names>RM</given-names></name><name><surname>Strauss</surname><given-names>AW</given-names></name><article-title>Expression of the mitochondrial creatine kinase genes</article-title><source>Mol Cell Biochem</source><year>1994</year><volume>133-134</volume><fpage>235</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1007/BF01267957</pub-id><pub-id pub-id-type="pmid">7808456</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><name><surname>Ventura-Clapier</surname><given-names>R</given-names></name><name><surname>Kuznetsov</surname><given-names>A</given-names></name><name><surname>Veksler</surname><given-names>V</given-names></name><name><surname>Boehm</surname><given-names>E</given-names></name><name><surname>Anflous</surname><given-names>K</given-names></name><article-title>Functional coupling of creatine kinases in muscles: species and tissue specificity</article-title><source>Mol Cell Biochem</source><year>1998</year><volume>184</volume><issue>1-2</issue><fpage>231</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1023/A:1006840508139</pub-id><pub-id pub-id-type="pmid">9746324</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><name><surname>Gellerich</surname><given-names>FN</given-names></name><name><surname>Khuchua</surname><given-names>ZA</given-names></name><name><surname>Kuznetsov</surname><given-names>AV</given-names></name><article-title>Influence of the mitochondrial outer membrane and the binding of creatine kinase to the mitochondrial inner membrane on the compartmentation of adenine nucleotides in the intermembrane space of rat heart mitochondria</article-title><source>Biochim Biophys Acta</source><year>1993</year><volume>1140</volume><issue>3</issue><fpage>327</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1016/0005-2728(93)90073-O</pub-id><pub-id pub-id-type="pmid">8417781</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><name><surname>Wallimann</surname><given-names>T</given-names></name><name><surname>Wyss</surname><given-names>M</given-names></name><name><surname>Brdiczka</surname><given-names>D</given-names></name><name><surname>Nicolay</surname><given-names>K</given-names></name><name><surname>Eppenberger</surname><given-names>HM</given-names></name><article-title>Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis</article-title><source>Biochem J</source><year>1992</year><volume>281</volume><issue>Pt 1</issue><fpage>21</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">1731757</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="other"><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Katz</surname><given-names>LM</given-names></name><name><surname>MacHugh</surname><given-names>DE</given-names></name><name><surname>McGivney</surname><given-names>BA</given-names></name><name><surname>Park</surname><given-names>SD</given-names></name><name><surname>Hill</surname><given-names>EW</given-names></name><article-title>Sequence variants in equine CKM (creatine kinase, muscle) and COX4I2 (cytochrome c oxidase, subunit 4, isoform 2) genes are associated with elite racing performance in Thoroughbred horses</article-title><source>International Conference on Equine Exercise Physiology: 2010; Cape Town, South Africa</source><year>2010</year></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Orr</surname><given-names>N</given-names></name><name><surname>Park</surname><given-names>SD</given-names></name><name><surname>Katz</surname><given-names>LM</given-names></name><name><surname>Sulimova</surname><given-names>G</given-names></name><name><surname>MacHugh</surname><given-names>DE</given-names></name><name><surname>Hill</surname><given-names>EW</given-names></name><article-title>A genome scan for positive selection in thoroughbred horses</article-title><source>PLoS One</source><year>2009</year><volume>4</volume><issue>6</issue><fpage>e5767</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0005767</pub-id><pub-id pub-id-type="pmid">19503617</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="other"><name><surname>MacLeod</surname><given-names>JN</given-names></name><article-title>Analysis Of Equine Gene Expression By RNA Sequencing</article-title><source>Plant &#x00026; Animal Genome Conference XVIII: 2009; San Diego, CA, USA</source><year>2009</year></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><name><surname>Rivero</surname><given-names>JL</given-names></name><name><surname>Galisteo</surname><given-names>AM</given-names></name><name><surname>Aguera</surname><given-names>E</given-names></name><name><surname>Miro</surname><given-names>F</given-names></name><article-title>Skeletal muscle histochemistry in male and female Andalusian and Arabian horses of different ages</article-title><source>Res Vet Sci</source><year>1993</year><volume>54</volume><issue>2</issue><fpage>160</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">8460254</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><name><surname>Sekoguchi</surname><given-names>E</given-names></name><name><surname>Sato</surname><given-names>N</given-names></name><name><surname>Yasui</surname><given-names>A</given-names></name><name><surname>Fukada</surname><given-names>S</given-names></name><name><surname>Nimura</surname><given-names>Y</given-names></name><name><surname>Aburatani</surname><given-names>H</given-names></name><name><surname>Ikeda</surname><given-names>K</given-names></name><name><surname>Matsuura</surname><given-names>A</given-names></name><article-title>A novel mitochondrial carnitine-acylcarnitine translocase induced by partial hepatectomy and fasting</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><issue>40</issue><fpage>38796</fpage><lpage>38802</lpage><pub-id pub-id-type="doi">10.1074/jbc.M306372200</pub-id><pub-id pub-id-type="pmid">12882971</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><name><surname>Orii</surname><given-names>KO</given-names></name><name><surname>Aoyama</surname><given-names>T</given-names></name><name><surname>Souri</surname><given-names>M</given-names></name><name><surname>Orii</surname><given-names>KE</given-names></name><name><surname>Kondo</surname><given-names>N</given-names></name><name><surname>Orii</surname><given-names>T</given-names></name><name><surname>Hashimoto</surname><given-names>T</given-names></name><article-title>Genomic DNA organization of human mitochondrial very-long-chain acyl-CoA dehydrogenase and mutation analysis</article-title><source>Biochem Biophys Res Commun</source><year>1995</year><volume>217</volume><issue>3</issue><fpage>987</fpage><lpage>992</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1995.2867</pub-id><pub-id pub-id-type="pmid">8554625</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><name><surname>Matthews</surname><given-names>CE</given-names></name><name><surname>Ockene</surname><given-names>IS</given-names></name><name><surname>Freedson</surname><given-names>PS</given-names></name><name><surname>Rosal</surname><given-names>MC</given-names></name><name><surname>Merriam</surname><given-names>PA</given-names></name><name><surname>Hebert</surname><given-names>JR</given-names></name><article-title>Moderate to vigorous physical activity and risk of upper-respiratory tract infection</article-title><source>Med Sci Sports Exerc</source><year>2002</year><volume>34</volume><issue>8</issue><fpage>1242</fpage><lpage>1248</lpage><pub-id pub-id-type="doi">10.1097/00005768-200208000-00003</pub-id><pub-id pub-id-type="pmid">12165677</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><name><surname>Gleeson</surname><given-names>M</given-names></name><article-title>Mucosal immune responses and risk of respiratory illness in elite athletes</article-title><source>Exerc Immunol Rev</source><year>2000</year><volume>6</volume><fpage>5</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">10919060</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="other"><name><surname>Bouwman</surname><given-names>FG</given-names></name><name><surname>van Ginneken</surname><given-names>MM</given-names></name><name><surname>Noben</surname><given-names>JP</given-names></name><name><surname>Royackers</surname><given-names>E</given-names></name><name><surname>de Graaf-Roelfsema</surname><given-names>E</given-names></name><name><surname>Wijnberg</surname><given-names>ID</given-names></name><name><surname>van der Kolk</surname><given-names>JH</given-names></name><name><surname>Mariman</surname><given-names>EC</given-names></name><name><surname>van Breda</surname><given-names>E</given-names></name><article-title>Differential expression of equine muscle biopsy proteins during normal training and intensified training in young standardbred horses using proteomics technology</article-title><source>Comp Biochem Physiol Part D Genomics Proteomics</source><volume>5</volume><issue>1</issue><fpage>55</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.cbd.2009.11.001</pub-id><pub-id pub-id-type="pmid">20374942</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><name><surname>Stefansson</surname><given-names>S</given-names></name><name><surname>Yepes</surname><given-names>M</given-names></name><name><surname>Gorlatova</surname><given-names>N</given-names></name><name><surname>Day</surname><given-names>DE</given-names></name><name><surname>Moore</surname><given-names>EG</given-names></name><name><surname>Zabaleta</surname><given-names>A</given-names></name><name><surname>McMahon</surname><given-names>GA</given-names></name><name><surname>Lawrence</surname><given-names>DA</given-names></name><article-title>Mutants of plasminogen activator inhibitor-1 designed to inhibit neutrophil elastase and cathepsin G are more effective in vivo than their endogenous inhibitors</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><issue>29</issue><fpage>29981</fpage><lpage>29987</lpage><pub-id pub-id-type="doi">10.1074/jbc.M401913200</pub-id><pub-id pub-id-type="pmid">15131125</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><name><surname>Dufaux</surname><given-names>B</given-names></name><name><surname>Order</surname><given-names>U</given-names></name><article-title>Plasma elastase-alpha 1-antitrypsin, neopterin, tumor necrosis factor, and soluble interleukin-2 receptor after prolonged exercise</article-title><source>Int J Sports Med</source><year>1989</year><volume>10</volume><issue>6</issue><fpage>434</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1055/s-2007-1024939</pub-id><pub-id pub-id-type="pmid">2628363</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><name><surname>Pyne</surname><given-names>DB</given-names></name><article-title>Regulation of neutrophil function during exercise</article-title><source>Sports Med</source><year>1994</year><volume>17</volume><issue>4</issue><fpage>245</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.2165/00007256-199417040-00005</pub-id><pub-id pub-id-type="pmid">8009138</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><name><surname>Shephard</surname><given-names>RJ</given-names></name><name><surname>Shek</surname><given-names>PN</given-names></name><article-title>Immune responses to inflammation and trauma: a physical training model</article-title><source>Can J Physiol Pharmacol</source><year>1998</year><volume>76</volume><issue>5</issue><fpage>469</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1139/cjpp-76-5-469</pub-id><pub-id pub-id-type="pmid">9839070</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><name><surname>Moldoveanu</surname><given-names>AI</given-names></name><name><surname>Shephard</surname><given-names>RJ</given-names></name><name><surname>Shek</surname><given-names>PN</given-names></name><article-title>The cytokine response to physical activity and training</article-title><source>Sports Med</source><year>2001</year><volume>31</volume><issue>2</issue><fpage>115</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.2165/00007256-200131020-00004</pub-id><pub-id pub-id-type="pmid">11227979</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><name><surname>Niess</surname><given-names>AM</given-names></name><name><surname>Dickhuth</surname><given-names>HH</given-names></name><name><surname>Northoff</surname><given-names>H</given-names></name><name><surname>Fehrenbach</surname><given-names>E</given-names></name><article-title>Free radicals and oxidative stress in exercise--immunological aspects</article-title><source>Exerc Immunol Rev</source><year>1999</year><volume>5</volume><fpage>22</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">10519061</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><name><surname>Dousset</surname><given-names>E</given-names></name><name><surname>Avela</surname><given-names>J</given-names></name><name><surname>Ishikawa</surname><given-names>M</given-names></name><name><surname>Kallio</surname><given-names>J</given-names></name><name><surname>Kuitunen</surname><given-names>S</given-names></name><name><surname>Kyrolainen</surname><given-names>H</given-names></name><name><surname>Linnamo</surname><given-names>V</given-names></name><name><surname>Komi</surname><given-names>PV</given-names></name><article-title>Bimodal recovery pattern in human skeletal muscle induced by exhaustive stretch-shortening cycle exercise</article-title><source>Med Sci Sports Exerc</source><year>2007</year><volume>39</volume><issue>3</issue><fpage>453</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1249/mss.0b013e31802dd74e</pub-id><pub-id pub-id-type="pmid">17473771</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><name><surname>Phillips</surname><given-names>SM</given-names></name><name><surname>Tipton</surname><given-names>KD</given-names></name><name><surname>Ferrando</surname><given-names>AA</given-names></name><name><surname>Wolfe</surname><given-names>RR</given-names></name><article-title>Resistance training reduces the acute exercise-induced increase in muscle protein turnover</article-title><source>Am J Physiol</source><year>1999</year><volume>276</volume><issue>1 Pt 1</issue><fpage>E118</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">9886957</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><name><surname>Tipton</surname><given-names>KD</given-names></name><name><surname>Ferrando</surname><given-names>AA</given-names></name><name><surname>Phillips</surname><given-names>SM</given-names></name><name><surname>Doyle</surname><given-names>D</given-names><suffix>Jr</suffix></name><name><surname>Wolfe</surname><given-names>RR</given-names></name><article-title>Postexercise net protein synthesis in human muscle from orally administered amino acids</article-title><source>Am J Physiol</source><year>1999</year><volume>276</volume><issue>4 Pt 1</issue><fpage>E628</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">10198297</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><name><surname>Reppert</surname><given-names>SM</given-names></name><name><surname>Weaver</surname><given-names>DR</given-names></name><article-title>Coordination of circadian timing in mammals</article-title><source>Nature</source><year>2002</year><volume>418</volume><issue>6901</issue><fpage>935</fpage><lpage>941</lpage><pub-id pub-id-type="doi">10.1038/nature00965</pub-id><pub-id pub-id-type="pmid">12198538</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><name><surname>Oishi</surname><given-names>K</given-names></name><name><surname>Sakamoto</surname><given-names>K</given-names></name><name><surname>Okada</surname><given-names>T</given-names></name><name><surname>Nagase</surname><given-names>T</given-names></name><name><surname>Ishida</surname><given-names>N</given-names></name><article-title>Antiphase circadian expression between BMAL1 and period homologue mRNA in the suprachiasmatic nucleus and peripheral tissues of rats</article-title><source>Biochem Biophys Res Commun</source><year>1998</year><volume>253</volume><issue>2</issue><fpage>199</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1998.9779</pub-id><pub-id pub-id-type="pmid">9878515</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><name><surname>Atkinson</surname><given-names>G</given-names></name><name><surname>Edwards</surname><given-names>B</given-names></name><name><surname>Reilly</surname><given-names>T</given-names></name><name><surname>Waterhouse</surname><given-names>J</given-names></name><article-title>Exercise as a synchroniser of human circadian rhythms: an update and discussion of the methodological problems</article-title><source>Eur J Appl Physiol</source><year>2007</year><volume>99</volume><issue>4</issue><fpage>331</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1007/s00421-006-0361-z</pub-id><pub-id pub-id-type="pmid">17165050</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><name><surname>Stokkan</surname><given-names>KA</given-names></name><name><surname>Yamazaki</surname><given-names>S</given-names></name><name><surname>Tei</surname><given-names>H</given-names></name><name><surname>Sakaki</surname><given-names>Y</given-names></name><name><surname>Menaker</surname><given-names>M</given-names></name><article-title>Entrainment of the circadian clock in the liver by feeding</article-title><source>Science</source><year>2001</year><volume>291</volume><issue>5503</issue><fpage>490</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1126/science.291.5503.490</pub-id><pub-id pub-id-type="pmid">11161204</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><name><surname>Edgar</surname><given-names>DM</given-names></name><name><surname>Dement</surname><given-names>WC</given-names></name><article-title>Regularly scheduled voluntary exercise synchronizes the mouse circadian clock</article-title><source>Am J Physiol</source><year>1991</year><volume>261</volume><issue>4 Pt 2</issue><fpage>R928</fpage><lpage>933</lpage><pub-id pub-id-type="pmid">1928438</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><name><surname>Piccione</surname><given-names>G</given-names></name><name><surname>Grasso</surname><given-names>F</given-names></name><name><surname>Fazio</surname><given-names>F</given-names></name><name><surname>Giudice</surname><given-names>E</given-names></name><article-title>The effect of physical exercise on the daily rhythm of platelet aggregation and body temperature in horses</article-title><source>Vet J</source><year>2008</year><volume>176</volume><issue>2</issue><fpage>216</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1016/j.tvjl.2007.01.026</pub-id><pub-id pub-id-type="pmid">17408996</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><name><surname>Murphy</surname><given-names>BA</given-names></name><name><surname>Vick</surname><given-names>MM</given-names></name><name><surname>Sessions</surname><given-names>DR</given-names></name><name><surname>Cook</surname><given-names>RF</given-names></name><name><surname>Fitzgerald</surname><given-names>BP</given-names></name><article-title>Evidence of an oscillating peripheral clock in an equine fibroblast cell line and adipose tissue but not in peripheral blood</article-title><source>Journal of comparative physiology</source><year>2006</year><volume>192</volume><issue>7</issue><fpage>743</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1007/s00359-006-0108-7</pub-id><pub-id pub-id-type="pmid">16479406</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><name><surname>Souissi</surname><given-names>N</given-names></name><name><surname>Gauthier</surname><given-names>A</given-names></name><name><surname>Sesboue</surname><given-names>B</given-names></name><name><surname>Larue</surname><given-names>J</given-names></name><name><surname>Davenne</surname><given-names>D</given-names></name><article-title>Effects of regular training at the same time of day on diurnal fluctuations in muscular performance</article-title><source>J Sports Sci</source><year>2002</year><volume>20</volume><issue>11</issue><fpage>929</fpage><lpage>937</lpage><pub-id pub-id-type="doi">10.1080/026404102320761813</pub-id><pub-id pub-id-type="pmid">12430993</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><name><surname>Reilly</surname><given-names>T</given-names></name><name><surname>Atkinson</surname><given-names>G</given-names></name><name><surname>Edwards</surname><given-names>B</given-names></name><name><surname>Waterhouse</surname><given-names>J</given-names></name><name><surname>Farrelly</surname><given-names>K</given-names></name><name><surname>Fairhurst</surname><given-names>E</given-names></name><article-title>Diurnal variation in temperature, mental and physical performance, and tasks specifically related to football (soccer)</article-title><source>Chronobiol Int</source><year>2007</year><volume>24</volume><issue>3</issue><fpage>507</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1080/07420520701420709</pub-id><pub-id pub-id-type="pmid">17612948</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><name><surname>Brisswalter</surname><given-names>J</given-names></name><name><surname>Bieuzen</surname><given-names>F</given-names></name><name><surname>Giacomoni</surname><given-names>M</given-names></name><name><surname>Tricot</surname><given-names>V</given-names></name><name><surname>Falgairette</surname><given-names>G</given-names></name><article-title>Morning-to-evening differences in oxygen uptake kinetics in short-duration cycling exercise</article-title><source>Chronobiol Int</source><year>2007</year><volume>24</volume><issue>3</issue><fpage>495</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1080/07420520701420691</pub-id><pub-id pub-id-type="pmid">17612947</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><name><surname>Morris</surname><given-names>C</given-names></name><name><surname>Atkinson</surname><given-names>G</given-names></name><name><surname>Drust</surname><given-names>B</given-names></name><name><surname>Marrin</surname><given-names>K</given-names></name><name><surname>Gregson</surname><given-names>W</given-names></name><article-title>Human core temperature responses during exercise and subsequent recovery: an important interaction between diurnal variation and measurement site</article-title><source>Chronobiol Int</source><year>2009</year><volume>26</volume><issue>3</issue><fpage>560</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1080/07420520902885981</pub-id><pub-id pub-id-type="pmid">19360496</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><name><surname>Suter</surname><given-names>E</given-names></name><name><surname>Hoppeler</surname><given-names>H</given-names></name><name><surname>Claassen</surname><given-names>H</given-names></name><name><surname>Billeter</surname><given-names>R</given-names></name><name><surname>Aebi</surname><given-names>U</given-names></name><name><surname>Horber</surname><given-names>F</given-names></name><name><surname>Jaeger</surname><given-names>P</given-names></name><name><surname>Marti</surname><given-names>B</given-names></name><article-title>Ultrastructural modification of human skeletal muscle tissue with 6-month moderate-intensity exercise training</article-title><source>Int J Sports Med</source><year>1995</year><volume>16</volume><issue>3</issue><fpage>160</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1055/s-2007-972985</pub-id><pub-id pub-id-type="pmid">7649706</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><name><surname>Desplanches</surname><given-names>D</given-names></name><name><surname>Hoppeler</surname><given-names>H</given-names></name><name><surname>Linossier</surname><given-names>MT</given-names></name><name><surname>Denis</surname><given-names>C</given-names></name><name><surname>Claassen</surname><given-names>H</given-names></name><name><surname>Dormois</surname><given-names>D</given-names></name><name><surname>Lacour</surname><given-names>JR</given-names></name><name><surname>Geyssant</surname><given-names>A</given-names></name><article-title>Effects of training in normoxia and normobaric hypoxia on human muscle ultrastructure</article-title><source>Pflugers Arch</source><year>1993</year><volume>425</volume><issue>3-4</issue><fpage>263</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1007/BF00374176</pub-id><pub-id pub-id-type="pmid">8309787</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><name><surname>Howald</surname><given-names>H</given-names></name><name><surname>Hoppeler</surname><given-names>H</given-names></name><name><surname>Claassen</surname><given-names>H</given-names></name><name><surname>Mathieu</surname><given-names>O</given-names></name><name><surname>Straub</surname><given-names>R</given-names></name><article-title>Influences of endurance training on the ultrastructural composition of the different muscle fiber types in humans</article-title><source>Pflugers Arch</source><year>1985</year><volume>403</volume><issue>4</issue><fpage>369</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1007/BF00589248</pub-id><pub-id pub-id-type="pmid">4011389</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><name><surname>Hoppeler</surname><given-names>H</given-names></name><name><surname>Howald</surname><given-names>H</given-names></name><name><surname>Conley</surname><given-names>K</given-names></name><name><surname>Lindstedt</surname><given-names>SL</given-names></name><name><surname>Claassen</surname><given-names>H</given-names></name><name><surname>Vock</surname><given-names>P</given-names></name><name><surname>Weibel</surname><given-names>ER</given-names></name><article-title>Endurance training in humans: aerobic capacity and structure of skeletal muscle</article-title><source>J Appl Physiol</source><year>1985</year><volume>59</volume><issue>2</issue><fpage>320</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">4030584</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><name><surname>MacArthur</surname><given-names>DG</given-names></name><name><surname>North</surname><given-names>KN</given-names></name><article-title>ACTN3: A genetic influence on muscle function and athletic performance</article-title><source>Exerc Sport Sci Rev</source><year>2007</year><volume>35</volume><issue>1</issue><fpage>30</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1097/JES.0b013e31802d8874</pub-id><pub-id pub-id-type="pmid">17211191</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><name><surname>Hewitt</surname><given-names>JE</given-names></name><article-title>Abnormal glycosylation of dystroglycan in human genetic disease</article-title><source>Biochim Biophys Acta</source><year>2009</year><volume>1792</volume><issue>9</issue><fpage>853</fpage><lpage>861</lpage><pub-id pub-id-type="pmid">19539754</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><name><surname>Cohn</surname><given-names>RD</given-names></name><article-title>Dystroglycan: important player in skeletal muscle and beyond</article-title><source>Neuromuscul Disord</source><year>2005</year><volume>15</volume><issue>3</issue><fpage>207</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.nmd.2004.11.005</pub-id><pub-id pub-id-type="pmid">15725582</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><name><surname>Chin</surname><given-names>ER</given-names></name><article-title>Role of Ca2+/calmodulin-dependent kinases in skeletal muscle plasticity</article-title><source>J Appl Physiol</source><year>2005</year><volume>99</volume><issue>2</issue><fpage>414</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00015.2005</pub-id><pub-id pub-id-type="pmid">16020436</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><name><surname>Michel</surname><given-names>RN</given-names></name><name><surname>Chin</surname><given-names>ER</given-names></name><name><surname>Chakkalakal</surname><given-names>JV</given-names></name><name><surname>Eibl</surname><given-names>JK</given-names></name><name><surname>Jasmin</surname><given-names>BJ</given-names></name><article-title>Ca2+/calmodulin-based signalling in the regulation of the muscle fibre phenotype and its therapeutic potential via modulation of utrophin A and myostatin expression</article-title><source>Appl Physiol Nutr Metab</source><year>2007</year><volume>32</volume><issue>5</issue><fpage>921</fpage><lpage>929</lpage><pub-id pub-id-type="doi">10.1139/H07-093</pub-id><pub-id pub-id-type="pmid">18059617</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><name><surname>Tentori</surname><given-names>L</given-names></name><name><surname>Graziani</surname><given-names>G</given-names></name><article-title>Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk?</article-title><source>Pharmacol Res</source><year>2007</year><volume>55</volume><issue>5</issue><fpage>359</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2007.01.020</pub-id><pub-id pub-id-type="pmid">17349798</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="other"><name><surname>Saugy</surname><given-names>M</given-names></name><name><surname>Robinson</surname><given-names>N</given-names></name><name><surname>Saudan</surname><given-names>C</given-names></name><name><surname>Baume</surname><given-names>N</given-names></name><name><surname>Avois</surname><given-names>L</given-names></name><name><surname>Mangin</surname><given-names>P</given-names></name><article-title>Human growth hormone doping in sport</article-title><source>Br J Sports Med</source><year>2006</year><issue>40 Suppl 1</issue><fpage>i35</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1136/bjsm.2006.027573</pub-id><pub-id pub-id-type="pmid">16799101</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><name><surname>Firth</surname><given-names>SM</given-names></name><name><surname>Baxter</surname><given-names>RC</given-names></name><article-title>Cellular actions of the insulin-like growth factor binding proteins</article-title><source>Endocr Rev</source><year>2002</year><volume>23</volume><issue>6</issue><fpage>824</fpage><lpage>854</lpage><pub-id pub-id-type="doi">10.1210/er.2001-0033</pub-id><pub-id pub-id-type="pmid">12466191</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><name><surname>Ren</surname><given-names>H</given-names></name><name><surname>Yin</surname><given-names>P</given-names></name><name><surname>Duan</surname><given-names>C</given-names></name><article-title>IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop</article-title><source>J Cell Biol</source><year>2008</year><volume>182</volume><issue>5</issue><fpage>979</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1083/jcb.200712110</pub-id><pub-id pub-id-type="pmid">18762576</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><name><surname>Kuemmerle</surname><given-names>JF</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><article-title>Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates growth and IGF-I secretion in human intestinal smooth muscle by Ras-dependent activation of p38 MAP kinase and Erk1/2 pathways</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><issue>23</issue><fpage>20563</fpage><lpage>20571</lpage><pub-id pub-id-type="doi">10.1074/jbc.M200885200</pub-id><pub-id pub-id-type="pmid">11923300</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><name><surname>McPherron</surname><given-names>AC</given-names></name><name><surname>Lawler</surname><given-names>AM</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><article-title>Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member</article-title><source>Nature</source><year>1997</year><volume>387</volume><issue>6628</issue><fpage>83</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1038/387083a0</pub-id><pub-id pub-id-type="pmid">9139826</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><name><surname>Roth</surname><given-names>SM</given-names></name><name><surname>Martel</surname><given-names>GF</given-names></name><name><surname>Ferrell</surname><given-names>RE</given-names></name><name><surname>Metter</surname><given-names>EJ</given-names></name><name><surname>Hurley</surname><given-names>BF</given-names></name><name><surname>Rogers</surname><given-names>MA</given-names></name><article-title>Myostatin gene expression is reduced in humans with heavy-resistance strength training: a brief communication</article-title><source>Exp Biol Med (Maywood)</source><year>2003</year><volume>228</volume><issue>6</issue><fpage>706</fpage><lpage>709</lpage><pub-id pub-id-type="pmid">12773702</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Cross</surname><given-names>JM</given-names></name><name><surname>Bamman</surname><given-names>MM</given-names></name><article-title>Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women</article-title><source>Am J Physiol Endocrinol Metab</source><year>2005</year><volume>288</volume><issue>6</issue><fpage>E1110</fpage><lpage>1119</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00464.2004</pub-id><pub-id pub-id-type="pmid">15644458</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><name><surname>Catipovic</surname><given-names>B</given-names></name><article-title>Myostatin mutation associated with gross muscle hypertrophy in a child</article-title><source>N Engl J Med</source><year>2004</year><volume>351</volume><issue>10</issue><fpage>1030</fpage><lpage>1031</lpage><comment>author reply 1030-1031</comment><pub-id pub-id-type="doi">10.1056/NEJM200409023511018</pub-id><pub-id pub-id-type="pmid">15342814</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><name><surname>Grobet</surname><given-names>L</given-names></name><name><surname>Martin</surname><given-names>LJ</given-names></name><name><surname>Poncelet</surname><given-names>D</given-names></name><name><surname>Pirottin</surname><given-names>D</given-names></name><name><surname>Brouwers</surname><given-names>B</given-names></name><name><surname>Riquet</surname><given-names>J</given-names></name><name><surname>Schoeberlein</surname><given-names>A</given-names></name><name><surname>Dunner</surname><given-names>S</given-names></name><name><surname>Menissier</surname><given-names>F</given-names></name><name><surname>Massabanda</surname><given-names>J</given-names></name><etal/><article-title>A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle</article-title><source>Nat Genet</source><year>1997</year><volume>17</volume><issue>1</issue><fpage>71</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1038/ng0997-71</pub-id><pub-id pub-id-type="pmid">9288100</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><name><surname>McPherron</surname><given-names>AC</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><article-title>Double muscling in cattle due to mutations in the myostatin gene</article-title><source>Proc Natl Acad Sci USA</source><year>1997</year><volume>94</volume><issue>23</issue><fpage>12457</fpage><lpage>12461</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.23.12457</pub-id><pub-id pub-id-type="pmid">9356471</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><name><surname>Mosher</surname><given-names>DS</given-names></name><name><surname>Quignon</surname><given-names>P</given-names></name><name><surname>Bustamante</surname><given-names>CD</given-names></name><name><surname>Sutter</surname><given-names>NB</given-names></name><name><surname>Mellersh</surname><given-names>CS</given-names></name><name><surname>Parker</surname><given-names>HG</given-names></name><name><surname>Ostrander</surname><given-names>EA</given-names></name><article-title>A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs</article-title><source>PLoS Genet</source><year>2007</year><volume>3</volume><issue>5</issue><fpage>e79.</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.0030079</pub-id><pub-id pub-id-type="pmid">17530926</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><name><surname>Schuelke</surname><given-names>M</given-names></name><name><surname>Wagner</surname><given-names>KR</given-names></name><name><surname>Stolz</surname><given-names>LE</given-names></name><name><surname>Hubner</surname><given-names>C</given-names></name><name><surname>Riebel</surname><given-names>T</given-names></name><name><surname>Komen</surname><given-names>W</given-names></name><name><surname>Braun</surname><given-names>T</given-names></name><name><surname>Tobin</surname><given-names>JF</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><article-title>Myostatin mutation associated with gross muscle hypertrophy in a child</article-title><source>N Engl J Med</source><year>2004</year><volume>350</volume><issue>26</issue><fpage>2682</fpage><lpage>2688</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa040933</pub-id><pub-id pub-id-type="pmid">15215484</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><name><surname>Hill</surname><given-names>EW</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Eivers</surname><given-names>SS</given-names></name><name><surname>Fonseca</surname><given-names>RG</given-names></name><name><surname>McGivney</surname><given-names>BA</given-names></name><name><surname>Govindarajan</surname><given-names>P</given-names></name><name><surname>Orr</surname><given-names>N</given-names></name><name><surname>Katz</surname><given-names>LM</given-names></name><name><surname>Machugh</surname><given-names>DE</given-names></name><article-title>Correction: A Sequence Polymorphism in MSTN Predicts Sprinting Ability and Racing Stamina in Thoroughbred Horses</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><comment>2010/02/04 edn</comment><pub-id pub-id-type="doi">10.1371/journal.pone.0008645</pub-id><pub-id pub-id-type="pmid">20098749</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><name><surname>Lindholm</surname><given-names>A</given-names></name><name><surname>Piehl</surname><given-names>K</given-names></name><article-title>Fibre composition, enzyme activity and concentrations of metabolites and electrolytes in muscles of standardbred horses</article-title><source>Acta Vet Scand</source><year>1974</year><volume>15</volume><issue>3</issue><fpage>287</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">4137664</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="other"><name><surname>Dingboom</surname><given-names>EG</given-names></name><name><surname>Dijkstra</surname><given-names>G</given-names></name><name><surname>Enzerink</surname><given-names>E</given-names></name><name><surname>van Oudheusden</surname><given-names>HC</given-names></name><name><surname>Weijs</surname><given-names>WA</given-names></name><article-title>Postnatal muscle fibre composition of the gluteus medius muscle of Dutch Warmblood foals; maturation and the influence of exercise</article-title><source>Equine Vet J Suppl</source><year>1999</year><issue>31</issue><fpage>95</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">10999667</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="other"><name><surname>Hubbard</surname><given-names>TJ</given-names></name><name><surname>Aken</surname><given-names>BL</given-names></name><name><surname>Ayling</surname><given-names>S</given-names></name><name><surname>Ballester</surname><given-names>B</given-names></name><name><surname>Beal</surname><given-names>K</given-names></name><name><surname>Bragin</surname><given-names>E</given-names></name><name><surname>Brent</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Clapham</surname><given-names>P</given-names></name><name><surname>Clarke</surname><given-names>L</given-names></name><etal/><article-title>Ensembl 2009</article-title><source>Nucleic Acids Res</source><year>2009</year><issue>37 Database</issue><fpage>D690</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn828</pub-id><pub-id pub-id-type="pmid">19033362</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="other"><name><surname>Karolchik</surname><given-names>D</given-names></name><name><surname>Kuhn</surname><given-names>RM</given-names></name><name><surname>Baertsch</surname><given-names>R</given-names></name><name><surname>Barber</surname><given-names>GP</given-names></name><name><surname>Clawson</surname><given-names>H</given-names></name><name><surname>Diekhans</surname><given-names>M</given-names></name><name><surname>Giardine</surname><given-names>B</given-names></name><name><surname>Harte</surname><given-names>RA</given-names></name><name><surname>Hinrichs</surname><given-names>AS</given-names></name><name><surname>Hsu</surname><given-names>F</given-names></name><etal/><article-title>The UCSC Genome Browser Database: 2008 update</article-title><source>Nucleic Acids Res</source><year>2008</year><issue>36 Database</issue><fpage>D773</fpage><lpage>779</lpage><pub-id pub-id-type="pmid">18086701</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><article-title>Moderated statistical tests for assessing differences in tag abundance</article-title><source>Bioinformatics</source><year>2007</year><volume>23</volume><issue>21</issue><fpage>2881</fpage><lpage>2887</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btm453</pub-id><pub-id pub-id-type="pmid">17881408</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><name><surname>Dennis</surname><given-names>G</given-names><suffix>Jr</suffix></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Hosack</surname><given-names>DA</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Lane</surname><given-names>HC</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name><article-title>DAVID: Database for Annotation, Visualization, and Integrated Discovery</article-title><source>Genome Biol</source><year>2003</year><volume>4</volume><issue>5</issue><fpage>P3</fpage><pub-id pub-id-type="doi">10.1186/gb-2003-4-5-p3</pub-id><pub-id pub-id-type="pmid">12734009</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><name><surname>Huang da</surname><given-names>W</given-names></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name><article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title><source>Nat Protoc</source><year>2009</year><volume>4</volume><issue>1</issue><fpage>44</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id><pub-id pub-id-type="pmid">19131956</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><name><surname>Hosack</surname><given-names>DA</given-names></name><name><surname>Dennis</surname><given-names>G</given-names><suffix>Jr</suffix></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Lane</surname><given-names>HC</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name><article-title>Identifying biological themes within lists of genes with EASE</article-title><source>Genome Biol</source><year>2003</year><volume>4</volume><issue>10</issue><fpage>R70</fpage><pub-id pub-id-type="doi">10.1186/gb-2003-4-10-r70</pub-id><pub-id pub-id-type="pmid">14519205</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><name><surname>Al-Shahrour</surname><given-names>F</given-names></name><name><surname>Arbiza</surname><given-names>L</given-names></name><name><surname>Dopazo</surname><given-names>H</given-names></name><name><surname>Huerta-Cepas</surname><given-names>J</given-names></name><name><surname>Minguez</surname><given-names>P</given-names></name><name><surname>Montaner</surname><given-names>D</given-names></name><name><surname>Dopazo</surname><given-names>J</given-names></name><article-title>From genes to functional classes in the study of biological systems</article-title><source>BMC Bioinformatics</source><year>2007</year><volume>8</volume><fpage>114</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-8-114</pub-id><pub-id pub-id-type="pmid">17407596</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="other"><name><surname>Al-Shahrour</surname><given-names>F</given-names></name><name><surname>Minguez</surname><given-names>P</given-names></name><name><surname>Tarraga</surname><given-names>J</given-names></name><name><surname>Montaner</surname><given-names>D</given-names></name><name><surname>Alloza</surname><given-names>E</given-names></name><name><surname>Vaquerizas</surname><given-names>JM</given-names></name><name><surname>Conde</surname><given-names>L</given-names></name><name><surname>Blaschke</surname><given-names>C</given-names></name><name><surname>Vera</surname><given-names>J</given-names></name><name><surname>Dopazo</surname><given-names>J</given-names></name><article-title>BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments</article-title><source>Nucleic Acids Res</source><year>2006</year><issue>34 Web Server</issue><fpage>W472</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1093/nar/gkl172</pub-id><pub-id pub-id-type="pmid">16845052</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><name><surname>Benjamini</surname><given-names>Y</given-names></name><name><surname>Hochberg</surname><given-names>Y</given-names></name><article-title>Controlling the false discovery rate - a practical and powerful approach to multiple testing</article-title><source>Journal of the Royal Statistical Society Series B-Methodological</source><year>1995</year><volume>57</volume><issue>1</issue><fpage>289</fpage><lpage>300</lpage></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><name><surname>Cappelli</surname><given-names>K</given-names></name><name><surname>Felicetti</surname><given-names>M</given-names></name><name><surname>Capomaccio</surname><given-names>S</given-names></name><name><surname>Spinsanti</surname><given-names>G</given-names></name><name><surname>Silvestrelli</surname><given-names>M</given-names></name><name><surname>Supplizi</surname><given-names>AV</given-names></name><article-title>Exercise induced stress in horses: selection of the most stable reference genes for quantitative RT-PCR normalization</article-title><source>BMC Mol Biol</source><year>2008</year><volume>9</volume><fpage>49</fpage><pub-id pub-id-type="doi">10.1186/1471-2199-9-49</pub-id><pub-id pub-id-type="pmid">18489742</pub-id></mixed-citation></ref></ref-list></back></article>